<!DOCTYPE article
 PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.2 20190208//EN" "JATS-archivearticle1.dtd">
<article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="preprint"><?all-math-mml yes?><?use-mml?><?origin ukpmcpa?><front><journal-meta><journal-id journal-id-type="nlm-ta">bioRxiv</journal-id><journal-title-group><journal-title>bioRxiv : the preprint server for biology</journal-title></journal-title-group><issn pub-type="epub">2692-8205</issn></journal-meta><article-meta><article-id pub-id-type="manuscript">EMS199801</article-id><article-id pub-id-type="doi">10.1101/2024.10.31.621336</article-id><article-id pub-id-type="archive">PPR933341</article-id><article-version-alternatives><article-version article-version-type="status">preprint</article-version><article-version article-version-type="number">1</article-version></article-version-alternatives><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Genome-wide analysis of fitness determinants of <italic>Staphylococcus aureus</italic> during growth in milk</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Torrissen Mårli</surname><given-names>Marita</given-names></name><xref ref-type="aff" rid="A1">1</xref></contrib><contrib contrib-type="author"><name><surname>Anne Olsdatter Ohren</surname><given-names>Nordraak</given-names></name><xref ref-type="aff" rid="A1">1</xref></contrib><contrib contrib-type="author"><name><surname>de Bakker</surname><given-names>Vincent</given-names></name><xref ref-type="aff" rid="A2">2</xref></contrib><contrib contrib-type="author"><name><surname>Ruud Winther</surname><given-names>Anja</given-names></name><xref ref-type="aff" rid="A1">1</xref></contrib><contrib contrib-type="author"><name><surname>Liu</surname><given-names>Xue</given-names></name><xref ref-type="aff" rid="A2">2</xref><xref ref-type="aff" rid="A3">3</xref></contrib><contrib contrib-type="author"><name><surname>Veening</surname><given-names>Jan-Willem</given-names></name><xref ref-type="aff" rid="A2">2</xref></contrib><contrib contrib-type="author"><name><surname>Porcellato</surname><given-names>Davide</given-names></name><xref ref-type="aff" rid="A1">1</xref></contrib><contrib contrib-type="author"><name><surname>Kjos</surname><given-names>Morten</given-names></name><xref ref-type="aff" rid="A1">1</xref><xref ref-type="corresp" rid="CR1">*</xref></contrib></contrib-group><aff id="A1"><label>1</label>Faculty of Chemistry, Biotechnology and Food Science, <institution-wrap><institution-id institution-id-type="ror">https://ror.org/04a1mvv97</institution-id><institution>Norwegian University of Life Sciences</institution></institution-wrap>, <country country="NO">Norway</country></aff><aff id="A2"><label>2</label>Department of Fundamental Microbiology, <institution-wrap><institution-id institution-id-type="ror">https://ror.org/019whta54</institution-id><institution>University of Lausanne</institution></institution-wrap>, <country country="CH">Switzerland</country></aff><aff id="A3"><label>3</label>Guangdong Provincial Key Laboratory of Regional Immunity and Diseases, Department of Pathogen Biology, Shenzhen University Medical School, Shenzhen 518055, Guangdong, China</aff><author-notes><corresp id="CR1"><label>*</label>Corresponding author: Morten Kjos, <email>morten.kjos@nmbu.no</email></corresp></author-notes><pub-date pub-type="nihms-submitted"><day>02</day><month>11</month><year>2024</year></pub-date><pub-date pub-type="preprint"><day>31</day><month>10</month><year>2024</year></pub-date><permissions><ali:free_to_read/><license><ali:license_ref>https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This work is licensed under a <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">CC BY 4.0 International license</ext-link>.</license-p></license></permissions><abstract><p id="P1"><italic>Staphylococcus aureus</italic> is a major concern in the dairy industry due to its significance as a pathogen causing bovine mastitis as well as a source of food poisoning. The nutrient-rich milk environment supports bacterial growth, but the specific genetic determinants that facilitate <italic>S. aureus</italic> proliferation and persistence in milk are poorly understood. In this study, we conducted a genome-wide CRISPR interference sequencing (CRISPRi-seq) screen to identify fitness determinants essential for <italic>S. aureus</italic> growth and survival in milk. We identified 282 milk-essential genes, including those with key roles in DNA replication, protein synthesis, and metabolism. Comparative analysis with brain heart infusion (BHI) as growth medium, revealed 79 genes with differential fitness, highlighting specific adaptations required for growth in milk. Notably, we found that purine biosynthesis, folate cycle pathways, and metal acquisition were particularly important in this environment. Based on this, we further demonstrate that <italic>S. aureus</italic> is more sensitive to the folate inhibitors trimethoprim-sulfamethoxazole (TMP-SMX) in milk and identify several genes whose knockdown results in hypersensitivity to TMP-SMX in milk. Additionally, our analysis showed a relatively reduced importance of cell wall components, such as teichoic acids, for <italic>S. aureus</italic> fitness in milk, which is also reflected in reduced efficiency of antimicrobials targeting teichoic acids. Together, these findings provide new insights into the genetic basis of <italic>S. aureus</italic> fitness and antibiotic susceptibility in milk, offering directions for novel treatment strategies against bovine mastitis.</p></abstract></article-meta></front><body><sec id="S1" sec-type="intro"><title>Introduction</title><p id="P2"><italic>Staphylococcus aureus</italic> is known for causing a wide range of infections in both humans and animals. In the dairy industry, <italic>S. aureus</italic> is a significant cause of mastitis, an inflammation of the mammary gland which reduces milk quality and yield in dairy cattle [<xref ref-type="bibr" rid="R1">1</xref>]. This pathogen poses risks not only through intramammary infections but also by contaminating raw milk, where its ability to produce highly thermo-stable and protease-resistant enterotoxins can lead to foodborne illnesses [<xref ref-type="bibr" rid="R2">2</xref>, <xref ref-type="bibr" rid="R3">3</xref>].</p><p id="P3">Milk is a nutrient-rich medium that supports the growth of bacteria, including <italic>S. aureus</italic>, due to the abundance of carbohydrates, fats, proteins, vitamins, and minerals [<xref ref-type="bibr" rid="R4">4</xref>, <xref ref-type="bibr" rid="R5">5</xref>]. <italic>S. aureus</italic> efficiently hydrolyzes casein and ferments lactose, which further facilitates its proliferation in milk [<xref ref-type="bibr" rid="R6">6</xref>, <xref ref-type="bibr" rid="R7">7</xref>]. Beyond promoting replication, the milk environment can also modulate the expression of various virulence factors that enhance immune evasion and persistence. These factors include modifications to cell surface characteristics, such as increased capsular polysaccharide expression, which reduces susceptibility to phagocytosis, and the secretion of toxins like leukocidins that target and kill bovine neutrophils [<xref ref-type="bibr" rid="R8">8</xref>–<xref ref-type="bibr" rid="R10">10</xref>]. Additionally, growth in milk has been shown to promote the expression of biofilm-associated proteins facilitating adherence and colonization in staphylococci as well as lactose permeases for improved lactose uptake and extracellular proteases that break down milk proteins to provide essential peptides and amino acids [<xref ref-type="bibr" rid="R11">11</xref>–<xref ref-type="bibr" rid="R14">14</xref>]. Finally, upregulation of genes involved in purine and lysine biosynthesis has also been reported for <italic>S. aureus</italic> grown in milk [<xref ref-type="bibr" rid="R11">11</xref>].</p><p id="P4">Current mastitis treatment relies on antibiotics, with β-lactams such as penicillin being used most commonly. However, as penicillin resistance becomes an increasing problem, other categories of antimicrobials – including aminoglycosides, lincosamides, macrolides, and sulfonamides – are employed, alongside combination therapies like amoxicillin-clavulanic aid (AMC) and trimethoprim-sulfamethoxazole (TMP-SMX) [<xref ref-type="bibr" rid="R15">15</xref>–<xref ref-type="bibr" rid="R18">18</xref>]. TMP-SMX acts synergistically by inhibiting sequential steps in the folate pathway, thereby disrupting nucleotide biosynthesis [<xref ref-type="bibr" rid="R19">19</xref>]. However, the efficacy of TMP-SMX in the milk environment is poorly understood. Furthermore, effectively managing <italic>S. aureus</italic>-associated bovine mastitis is challenging due to inconsistent antibiotic efficacy influenced by host-level factors such as age, somatic cell count, and number of infected quarters, as well as pathogen-level factors, such as antimicrobial resistance [<xref ref-type="bibr" rid="R1">1</xref>, <xref ref-type="bibr" rid="R20">20</xref>]. The dairy environment complicates treatment as variations in nutrient availability, biofilm production, and the milk’s complex composition can alter bacterial susceptibility to antibiotics [<xref ref-type="bibr" rid="R20">20</xref>].</p><p id="P5">Despite existing studies on gene expression and regulation of <italic>S. aureus</italic> in milk, comprehensive knowledge on the genome-wide fitness determinants critical for <italic>S. aureus</italic> growth, survival and antibiotic susceptibility in this environment remains limited. This study aims to bridge this knowledge gap by exploring the genetic basis of <italic>S. aureus</italic> fitness in milk using a genome-wide pooled CRISPR interference sequencing (CRISPRi-seq) screening approach. This method enables precise, targeted knockdown of genes across the genome, allowing us to efficiently identify key genes and pathways critical for <italic>S. aureus</italic> adaptation to the milk environment, including those affecting TMP-SMX susceptibility. By identifying these fitness determinants, we aim to uncover potential vulnerabilities that could inform more effective treatment strategies against <italic>S. aureus</italic> infections in the dairy industry.</p></sec><sec id="S2" sec-type="results"><title>Results</title><sec id="S3"><title>Construction of a tetracycline-inducible CRISPRi system in <italic>Staphylococcus aureus</italic> NCTC8325-4</title><p id="P6">To enable genome-wide fitness quantification using CRISPRi-seq during growth of <italic>S. aureus</italic> strain NCTC8325-4 in milk, a stable and inducible CRISPRi system is essential. We initially evaluated the functionality of our two-plasmid, IPTG-inducible CRISPRi system, which has previously shown success in standard laboratory media [<xref ref-type="bibr" rid="R21">21</xref>]. To assess the functionality of the system, a CRISPRi strain targeting the essential gene <italic>pbp1</italic> was grown in ultra-high temperature (UHT) milk with and without IPTG induction and compared to a control strain harboring a non-targeting sgRNA. Colony-forming units per milliliter (CFU/ml) were determined at various time points. For the CRISPRi(<italic>pbp1</italic>) strain there was a clear reduction in growth compared to the control strain even without inducer (<xref ref-type="supplementary-material" rid="SD1">Fig S1</xref>), indicating leaky expression of <italic>dcas9</italic> in milk. Possibly, this is due to partial induction of the IPTG-inducible promoter by the structural analog lactose present in milk.</p><p id="P7">To address this limitation, we constructed a strain where <italic>dcas9</italic> expression is controlled by a tetracycline-inducible promoter (P<sub>tet</sub>) integrated into the chromosome of <italic>S. aureus</italic> NCTC83254 (<italic>tetR</italic>-P<sub>tet</sub>-<italic>dcas9</italic>, <xref ref-type="fig" rid="F1">Fig 1A</xref>). The P<sub>tet</sub> promoter allows induction by tetracycline (tet) or tetracycline-derivates such as anhydrotetracycline (aTc), and a similar system has been used in <italic>S. aureus</italic> JE2 [<xref ref-type="bibr" rid="R22">22</xref>]. Next, to test the functionality of the system in targeting an essential gene, the plasmid pVL2336-sgRNA(<italic>pbp1</italic>), which provides constitutive expression of the sgRNA targeting <italic>pbp1</italic>, was introduced into strain MM267. We initially validated the functionality of the CRISPRi system in brain heart infusion (BHI) medium, observing decreased growth of the <italic>pbp1</italic>-targeting strain only upon induction with aTc (concentrations between 7.5 and 120 ng/ml, <xref ref-type="fig" rid="F1">Fig 1B</xref>). For the further experiments, 30 ng/ml aTc was used. It should be noted that prolonged incubation (&gt;10 hours) led to a resurgence in growth of the inhibited strains, likely due to mutations in the CRISPRi regulatory system, consistent with observations in other studies [<xref ref-type="bibr" rid="R23">23</xref>]. We then tested the <italic>pbp1</italic>-knockdown strain in milk, with or without aTc induction (30 ng/ml), and measured CFU/ml at different time points. The <italic>pbp1</italic>-knockdown resulted in growth inhibition for the first eight hours of incubation (<xref ref-type="fig" rid="F1">Fig 1C</xref>), and importantly, in the absence of inducer, the strain exhibited growth comparable to the control strain. This suggests minimal leakage from the P<sub>tet</sub> promoter under these conditions, confirming the suitability of this CRISPRi-system for use in milk.</p></sec><sec id="S4"><title>Quantifying the fitness determinants of <italic>S. aureus</italic> in milk by CRISPRi-seq</title><p id="P8">To identify genes essential for the growth of <italic>S. aureus</italic> in milk, we utilized our previously constructed sgRNA library targeting 1928 transcriptional units (TUs) of the <italic>S. aureus</italic> NCTC8325-4 genome (targeting &gt; 97% of all genes) [<xref ref-type="bibr" rid="R21">21</xref>]. This library was transformed into <italic>S. aureus</italic> strain MM267 (NCTC8325-4, <italic>tetR</italic>-P<sub>tet</sub>-dCas9, <italic>tetM</italic>), resulting in a tetracycline-inducible, pooled CRISPRi library in <italic>S. aureus</italic> NCTC8325-4 (<xref ref-type="fig" rid="F2">Fig 2A</xref>). We conducted a CRISPRi-seq analysis in UHT milk, growing the CRISPRi library with or without aTc induction for ~20 generations at 37°C. The sgRNA abundances were determined by Illumina sequencing, as described previously [<xref ref-type="bibr" rid="R23">23</xref>] (<xref ref-type="fig" rid="F2">Fig 2A</xref>). Principle component analysis (PCA) of the samples showed clear separation between induced and uninduced conditions (<xref ref-type="supplementary-material" rid="SD1">Fig S2A</xref>). Fitness score analysis identified 282 targets with a log2 fold-change (L2FC) ≤ -1 with <italic>p</italic> &lt; 0.05, and these were categorized as essential for growth in milk (<xref ref-type="supplementary-material" rid="SD1">Fig S2B</xref>). A full list of milk-essential genes is provided in <xref ref-type="supplementary-material" rid="SD2">Table S1</xref>.</p></sec><sec id="S5"><title>Identifying milk-specific fitness determinants</title><p id="P9">Among the genes classified as essential in milk, many encode proteins involved in core cellular processes such as DNA replication, protein synthesis, cell division and central metabolic pathways; functions that are typically essential across various conditions (<xref ref-type="table" rid="T1">Table 1</xref>). To filter out genes specifically important for fitness in milk compared to another rich growth medium, we performed a similar CRISPRi-seq screen using the same library to quantify gene fitness in brain heart infusion (BHI) medium at 37°C. Again, PCA showed clear separation between induced and uninduced conditions, as well as a separation between BHI and milk conditions (<xref ref-type="supplementary-material" rid="SD1">Fig S2A</xref>). The small separation between the uninduced conditions, suggest that there may be a minor leakiness of the P<sub>tet</sub> system during the experiments, although this was not observed in our initial tests (<xref ref-type="fig" rid="F1">Fig. 1</xref>). In BHI, we identified 294 targets as essential for growth (L2FC ≤ -1 with <italic>p</italic> &lt; 0.05) (<xref ref-type="supplementary-material" rid="SD1">Fig S2C</xref>). Of these, 242 targets were classified as essential in both milk and BHI (<xref ref-type="fig" rid="F2">Fig 2B</xref>). To further distinguish between these conditions, we compared the fitness effects between milk and BHI (<xref ref-type="fig" rid="F2">Fig 2C</xref>). This analysis revealed 79 targets with significantly differential fitness in milk relative to BHI (|ΔL2FC| ≥ 1, <italic>p</italic> &lt; 0.05). Specifically, 25 sgRNA targets were significantly more important for fitness in milk than in BHI, while 54 sgRNA targets were significantly less important for fitness in milk compared to BHI (<xref ref-type="fig" rid="F2">Fig 2C</xref>, <xref ref-type="table" rid="T1">Table 1</xref>, <xref ref-type="supplementary-material" rid="SD1">Table S3</xref>).</p></sec><sec id="S6"><title>Purine and folate cycle metabolism are important for fitness during growth in milk</title><p id="P10">The CRISPRi-seq results highlighted that purine biosynthesis pathways were specifically important for <italic>S. aureus</italic> fitness in milk. Significant hits included the <italic>purE</italic> operon (<italic>purEKCSQLFMNHD</italic>, targeted by the <italic>purE</italic> sgRNA), along with the monocistronic <italic>purA</italic> and <italic>purB</italic> (<xref ref-type="table" rid="T1">Table 1</xref>, <xref ref-type="fig" rid="F3">Fig 3</xref>). The <italic>purE</italic> operon encodes enzymes that drive the conversion of phosphoribosyl pyrophosphate (PRPP) to inosine monophosphate (IMP), which is then converted to adenylosuccinate by <italic>purA</italic> and subsequently to AMP by <italic>purB.</italic> To validate these findings, we constructed individual CRISPRi strains with sgRNAs targeting <italic>purA</italic>, <italic>purB</italic> and <italic>purE,</italic> and compared their growth in BHI and milk to that of a control strain harboring a non-targeting sgRNA. The results showed that <italic>purB</italic> was particularly critical for growth in milk, also in this non-competitive setting, while <italic>purA</italic> and <italic>purE</italic> knockdowns exhibited milder growth defects (<xref ref-type="fig" rid="F3">Fig 3A-B</xref>).</p><p id="P11">The CRISPRi-seq results also emphasize the importance of directing precursors of the purine biosynthesis pathway, such as L-glutamine and ribulose-5-phosphate, towards purine biosynthesis rather than alternative pathways when <italic>S. aureus</italic> grow in milk. For example, depletion of <italic>glmS</italic> and <italic>pyrG</italic>, which utilize the <italic>purF</italic>-substate L-glutamine for peptidoglycan synthesis or L-glutamate synthesis, respectively, have less impact on fitness in milk compared to BHI (<xref ref-type="fig" rid="F3">Fig 3C</xref>, <xref ref-type="supplementary-material" rid="SD1">Table S3</xref>). The same trend is also seen for <italic>pgcA</italic> and <italic>rpiA</italic> which utilize ribulose-5-phosphate in alternative pathways (<xref ref-type="fig" rid="F3">Fig 3C</xref>, <xref ref-type="supplementary-material" rid="SD1">Table S3</xref>). Finally, we also observed that genes associated with the folate cycle (<italic>folD</italic>, <italic>metEF</italic>, <italic>thyA</italic>), which is intertwined with purine biosynthesis (<xref ref-type="fig" rid="F3">Fig 3C</xref>), also appear to be critical for optimal fitness in milk (<xref ref-type="fig" rid="F3">Fig 3B</xref>, <xref ref-type="table" rid="T1">Table 1</xref>).</p></sec><sec id="S7"><title>Increased sensitivity to trimethoprim-sulfamethoxazole in milk</title><p id="P12">Given that the results above point towards the importance of purine biosynthesis and the folate cycle for the fitness of <italic>S. aureus</italic> in milk, we explored the sensitivity of <italic>S. aureus</italic> to TMP-SMX under these conditions. TMP-SMX is a commonly used antibiotic combination inhibiting key enzymes in the bacterial folate pathway (TMP targets DfrA, while SMX targets FolP, <xref ref-type="fig" rid="F3">Fig 3C</xref>), which is crucial for nucleotide biosynthesis and ultimately DNA replication [<xref ref-type="bibr" rid="R25">25</xref>]. Given the close links between the folate pathway and the enzymes of the purine pathway and folate cycle, we compared the sensitivity of <italic>S. aureus</italic> towards TMP-SMX in milk with the sensitivity in BHI. Indeed, our results demonstrated that milk sensitized <italic>S. aureus</italic> to TMP-SMX treatment (<xref ref-type="fig" rid="F4">Fig 4A</xref>). Our data indicate that <italic>S. aureus</italic> is approximately 8-fold more sensitive to TMP-SMX in milk compared to BHI.</p></sec><sec id="S8"><title>Blocking of nucleoside import sensitizes <italic>S. aureus</italic> to TMP-SMX</title><p id="P13">Recent studies have shown the potential of emerging TMP-SMX resistance in <italic>S. aureus</italic> [<xref ref-type="bibr" rid="R26">26</xref>], and targets or pathways that can be used to increase the sensitivity or counteract resistance to TMP-SMX are therefore of interest. We performed an additional CRISPRi-seq experiment where we grew the CRISPRi library in milk, both with and without induction, exposing it to supra-MIC concentrations of TMP (0.1 μg/ml) and SMX (0.5 μg/ml), which correspond to a 2-fold MIC concentration, and incubated for 13 hours. This CRISPRi-seq screen identified several genes with a significant reduction in fold change (L2FC &lt; -1, <italic>P<sub>adj</sub></italic> &lt; 0.05) in the presence of TMP-SMX, suggesting that their knockdown sensitizes cells to TMP-SMX (<xref ref-type="fig" rid="F4">Fig 4B</xref>). The hits did not include genes directly involved in the folate biosynthesis pathway, possibly due to the essentiality of this pathway in milk. We selected the seven of the most significant targets from the screen for further experiments (<xref ref-type="fig" rid="F4">Fig 4B</xref>, <xref ref-type="table" rid="T2">Table 2</xref>). A complete overview of gene fitness upon TMP-SMX treatment is provided in <xref ref-type="supplementary-material" rid="SD2">Table S2</xref>.</p><p id="P14">The most prominent hit from the CRISPRi-seq screen was the nucleoside permease <italic>nupC</italic>. An individual CRISPRi strain targeting <italic>nupC</italic> for knockdown demonstrated dramatically increased sensitivity of <italic>S. aureus</italic> to TMP-SMX in milk (<xref ref-type="fig" rid="F4">Fig 4C-D</xref>). Although less prominent, another nucleoside permease, <italic>nupG</italic>, was found to have a similar effect in milk, but not BHI. TMP and SMX act synergistically to inhibit the production of dTMP, a vital precursor for DNA synthesis (<xref ref-type="fig" rid="F3">Fig 3C</xref>). Thus, when available from the environment, thymidine can be imported by NupC and/or NupG to partially bypass the effect of TMP-SMX. This blocking of thymidine-import likely sensitizes cells to TMP-SMX in thymidine-rich environments (<xref ref-type="fig" rid="F4">Fig 4E</xref>) [<xref ref-type="bibr" rid="R27">27</xref>].</p><p id="P15">For the remaining genes tested (<italic>polA, noc, ung, murB, SAOUHSC</italic> _01782, <italic>SAOUHSC</italic> _02121), individual CRISPRi-strains were also constructed. All these strains displayed increased sensitivity to TMP-SMX in milk. Four genes (<italic>polA</italic>, <italic>noc</italic>, <italic>murB</italic>, <italic>SAOUHSC</italic>_02121) also displaying increased susceptibility to TMP-SMX when knocked down in BHI, albeit indeed less strongly than in milk (<xref ref-type="fig" rid="F4">Fig 4C-D</xref>). The hits included several proteins linked to DNA metabolism, such as <italic>ung</italic>, encoding uracil-DNA glycosylase involved in DNA repair, and <italic>noc</italic>, which encodes a protein known to affect both cell division through nucleoid occlusion in addition to DNA replication in <italic>S. aureus</italic> [<xref ref-type="bibr" rid="R28">28</xref>, <xref ref-type="bibr" rid="R29">29</xref>]. Another target, <italic>polA</italic>, encodes DNA polymerase I, which is essential for DNA replication [<xref ref-type="bibr" rid="R28">28</xref>]. The yet uncharacterized genes SAOUHSC_02121 and SAOUHSC_01782 were also shown to result in increased sensitivity to TMP-SMX (<xref ref-type="fig" rid="F4">Fig 4C-D</xref>). Given the involvement of the other targets in DNA metabolism, we speculate that SAOUHSC_02121 and SAOUHSC_01782 have related roles in the cell, but this awaits further investigation.</p></sec><sec id="S9"><title>Genes associated with metal homeostasis affect growth fitness in milk</title><p id="P16">In addition to purine biosynthesis, CRISPRi-seq revealed several virulence-associated genes that were important for fitness in milk (<xref ref-type="table" rid="T1">Table 1</xref>). These included the regulator SarA, metal acquisition mechanisms involved in iron scavenging (<italic>htsA, fhuC</italic>), heme synthesis (<italic>hemQ</italic>) and manganese uptake (<italic>mntA</italic>). Single CRISPRi-strains were constructed for these genes and assayed for their ability to grow in milk, showing that <italic>fhuC, mntA</italic> and <italic>hemQ</italic> were particularly critical for growth in milk (<xref ref-type="fig" rid="F5">Fig 5A-B</xref>).</p></sec><sec id="S10"><title>Reduced importance of cell wall biosynthesis pathways for fitness in milk</title><p id="P17">The CRISPRi-seq analysis also identified several genes and pathways that are less critical for <italic>S. aureus</italic> fitness in milk compared to BHI. Notably, this included genes in the shikimate pathway and, intriguingly, teichoic acid biosynthesis (<xref ref-type="supplementary-material" rid="SD1">Table S3</xref>). For example, knockdown of genes involved in glycolipid/lipoteichoic acid synthesis (<italic>pgcA, gtaB, ugtP, ltaA</italic>) was detrimental for growth in BHI but not in milk, while the early steps of wall teichoic acid synthesis (<italic>tagO, tagA</italic>) also had a significantly reduced impact on fitness in milk compared to BHI, suggesting these genes are less critical for growth in the milk environment. The operon responsible for D-alanylation of teichoic acids, <italic>dltABCD</italic> (operon targeted at SAOUHSC_00867) was similarly less critical for growth in milk. We therefore hypothesized that the milk environment may affect the susceptibility to antimicrobials targeting teichoic acid biosynthesis. To test this, we examined the survival of cells treated with different concentrations of tunicamycin (targeting TagO) and targocil (targeting the wall teichoic acid exporter TarG) [<xref ref-type="bibr" rid="R30">30</xref>, <xref ref-type="bibr" rid="R31">31</xref>]. Indeed, in both cases, growth in milk protected <italic>S. aureus</italic> from the inhibitory effect of these compounds (<xref ref-type="fig" rid="F6">Fig 6A-B</xref>).</p></sec></sec><sec id="S11" sec-type="discussion"><title>Discussion</title><p id="P18">This study provides new insights into the genetic determinants of <italic>S. aureus</italic> fitness during growth in milk and contributes to the understanding of bacterial adaptation in the dairy environment. Through a genome-wide CRISPRi-seq screen, we identified key mechanisms and pathways that play critical roles in <italic>S. aureus</italic> survival and proliferation in milk. Furthermore, we have identified genes involved in the susceptibility to the antibiotic combination TMP-SMX. Together, our findings have implications for control of <italic>S. aureus</italic> in the milk environment and the use of antimicrobial agents in treating <italic>S. aureus</italic>-associated bovine mastitis.</p><p id="P19">Our results highlight that the milk environment, although rich in nutrients, poses specific fitness challenges for <italic>S. aureus</italic>, which differ from those in standard laboratory media such as BHI. While several cellular processes, including DNA replication and protein synthesis, are required across both environments, purine biosynthesis and the folate cycle stood out as particularly critical for growth in milk (<xref ref-type="table" rid="T1">Table 1</xref>, <xref ref-type="fig" rid="F3">Fig 3A-C</xref>). This finding aligns with previous studies showing that purine biosynthesis genes are upregulated in milk [<xref ref-type="bibr" rid="R11">11</xref>]. Purine biosynthesis is responsible for the production of purine nucleotides, essential for DNA and RNA synthesis, while the folate cycle provides one-carbon units needed for the biosynthesis of purines, thymine, and methionine (<xref ref-type="fig" rid="F3">Fig 3C</xref>). The reliance on purine and folate metabolism is likely linked to the nutrient composition of milk, which may lack sufficient external sources of folate and purines for scavenging, forcing <italic>S. aureus</italic> to depend on its <italic>de novo</italic> biosynthetic pathways to sustain proliferation in milk. The importance of purine biosynthesis for <italic>S. aureus</italic> virulence is well established, and <italic>de novo</italic> purine biosynthesis has been shown to be required for the pathogenesis and virulence of <italic>S. aureus</italic> [<xref ref-type="bibr" rid="R32">32</xref>–<xref ref-type="bibr" rid="R36">36</xref>]. Our findings suggest that the milk environment may promote <italic>S. aureus</italic> to establish and maintain infection through the dependence of this pathway.</p><p id="P20">The antibiotic combination TMP-SMX inhibits synthesis of folates and thereby DNA synthesis (<xref ref-type="fig" rid="F3">Fig 3C</xref>). TMP inhibits dihydrofolate reductase (DfrA), while SMX inhibits dihydropteroate synthase (FolP), both of which are crucial steps in the folate biosynthesis pathway. Our results demonstrate that <italic>S. aureus</italic> is clearly more sensitive to TMP-SMX in milk compared to BHI (<xref ref-type="fig" rid="F4">Fig 4A</xref>). Interestingly, this finding contrasts with the observed reduced efficacy of penicillin G in the milk environment, which has been attributed to be due to the protective effect of milk components [<xref ref-type="bibr" rid="R37">37</xref>, <xref ref-type="bibr" rid="R38">38</xref>] and the diminished activity of teichoic acid biosynthesis-targeting compounds observed in this study (<xref ref-type="fig" rid="F6">Fig 6</xref>). These results underscore how the milk environment can both improve or reduce the efficiency of antimicrobials, depending on their mechanism. Specifically, the differential efficacy observed for TMP-SMX highlights the potential for using TMP-SMX more strategically in the milk environment, in cases of penicillin-resistant <italic>S. aureus</italic> or when penicillin efficacy is compromised.</p><p id="P21">To further explore the mechanisms underlying TMP-SMX susceptibility in milk, we performed a CRISPRi-seq screen, exposing the library to supra-MIC concentrations of TMP-SMX. The screen identified eight genes whose knockdown significantly increased sensitivity to TMP-SMX (<xref ref-type="table" rid="T2">Table 2</xref>, <xref ref-type="fig" rid="F4">Fig 4B-D</xref>). Our results suggest that <italic>S. aureus</italic> survival in the presence of TMP-SMX relies on environmental salvage of thymidine and/or other nucleosides, making import of nucleosides via NupC and NupG essential in this setting. The screen also identified genes involved in DNA repair (<italic>polA, noc, ung</italic>) as essential, likely because TMP-SMX induces DNA replication stress, making DNA integrity and DNA repair pathways particularly critical for survival. These genes offer potential targets for novel treatments, either alone or in combination with TMP-SMX, to further sensitize <italic>S. aureus</italic>. Indeed, fluoroquinolones, which inhibit DNA replication, such as gemifloxacin, have already been shown to act synergistically with TMP-SMX against <italic>S. aureus</italic> [<xref ref-type="bibr" rid="R39">39</xref>].</p><p id="P22">Furthermore, our screen revealed several virulence-associated genes that are critical for fitness in milk, particularly those involved in metal acquisition. Uptake systems for iron (<italic>htsABC</italic>, <italic>fhuC</italic>) and manganese (<italic>mntABC</italic>) were essential for growth with knockdown significantly impairing bacterial fitness (<xref ref-type="table" rid="T1">Table 1</xref>). In milk, iron is limited due to sequestration by lactoferrin, transferrin, and casein, while manganese is restricted by calprotectin, both of which are part of the host’s innate immune defense [<xref ref-type="bibr" rid="R40">40</xref>–<xref ref-type="bibr" rid="R44">44</xref>]. In general, the concentration of iron in milk ranges from 0.2 to 0.3 μg/ml, while manganese levels range from 0.02 μg/ml to 0.16 μg/ml [<xref ref-type="bibr" rid="R44">44</xref>]. In response, <italic>S. aureus</italic> relies heavily on high-affinity metal scavenging systems, using siderophores like staphyloferrin A and B to capture iron and transport it into the cell via HtsABC and SirABC, powered by the ATPase FhuC [<xref ref-type="bibr" rid="R40">40</xref>, <xref ref-type="bibr" rid="R41">41</xref>, <xref ref-type="bibr" rid="R45">45</xref>, <xref ref-type="bibr" rid="R46">46</xref>]. Similarly, manganese uptake is mediated by the MntABC and MntH transporters [<xref ref-type="bibr" rid="R40">40</xref>, <xref ref-type="bibr" rid="R47">47</xref>]. While <italic>htsA</italic> displayed significantly reduced fitness in the CRISPRi-seq screen, the single knockdown strain did not show a substantial reduction in growth (<xref ref-type="fig" rid="F5">Fig 5A-B</xref>). This is likely due to the competitive nature of the pooled CRISPRi library, in which relatively mild fitness defects will be more easily detected compared to growth of single knockdown strains. For example, in the pooled library, other bacterial cells will take up and contribute to depletion of iron in the environment, thereby making it even harder for <italic>htsA</italic> knockdown strains to grow compared to pure culture of the same strain. Targeting iron and manganese acquisition systems represents a potential therapeutic strategy to limit <italic>S. aureus</italic> proliferation in the milk environment. Indeed, lactoferrin has shown inhibitory effects alone, and in combination with penicillin, on <italic>S. aureus</italic>, highlighting the potential for combination therapies [<xref ref-type="bibr" rid="R48">48</xref>–<xref ref-type="bibr" rid="R50">50</xref>].</p><p id="P23">Additionally, our screen indicated that the transcriptional regulator, SarA, was important for fitness of <italic>S. aureus</italic> in milk (<xref ref-type="table" rid="T1">Table 1</xref>). SarA plays a central role in regulating numerous processes, including the upregulation of fibronectin- and fibrinogen-binding proteins, hemolysins, toxins, oxidative stress response genes, and biofilm formation, while repressing expression of proteases, protein A, and collagen-binding proteins [<xref ref-type="bibr" rid="R51">51</xref>–<xref ref-type="bibr" rid="R54">54</xref>]. It also modulates the expression of other regulatory loci [<xref ref-type="bibr" rid="R54">54</xref>–<xref ref-type="bibr" rid="R57">57</xref>], making its overall role in bacterial fitness and virulence complex. Given the broad range of processes influenced by SarA, further investigation is needed to understand the specific functions of SarA in this environment.</p><p id="P24">In contrast to previous studies [<xref ref-type="bibr" rid="R14">14</xref>], we did not observe a contribution of secreted extracellular proteases to <italic>S. aureus</italic> fitness in milk. This is probably due to our experimental design using a pooled library. Here, extracellular proteases secreted to the medium will be public goods, possibly masking any effect of knockdown in individual strains. Additionally, we harvested cells in the exponential growth phase, and it is likely that secreted proteases contribute more during longer incubation periods when nutrient sources in the milk become depleted, as suggested earlier [<xref ref-type="bibr" rid="R14">14</xref>]. It should also be noted that the high temperature treatment of the milk used in our experiments, probably results in changes in the protein composition which may also influence the results [<xref ref-type="bibr" rid="R58">58</xref>].</p><p id="P25">Interestingly, due to the use of CRISPRi-seq, we could also identify pathways that are essential in normal growth medium, but redundant or less important for fitness in milk, (<xref ref-type="supplementary-material" rid="SD1">Table S3</xref>, <xref ref-type="fig" rid="F3">Fig 3C</xref>). This includes the Shikimate pathway (e.g., <italic>aroA, aroA2, aroB, aroK, aroE</italic> as well as <italic>menA</italic>) essential for the synthesis of aromatic amino acids and menaquinone (vitamin K). This suggests that <italic>S. aureus</italic> acquires these metabolites from the milk environment. As a result, targeting the Shikimate pathway, which has been proposed as an antimicrobial target [<xref ref-type="bibr" rid="R59">59</xref>, <xref ref-type="bibr" rid="R60">60</xref>], may be less effective in treating milk-associated infections like mastitis. Additionally, genes involved in teichoic acid and glycolipid biosynthesis, such as <italic>pgcA, gtaB,</italic> and <italic>ugtP-ltaA</italic>, which are required for growth in BHI, were found to be non-essential in milk (<xref ref-type="supplementary-material" rid="SD1">Table S3</xref>). Furthermore, TagO and TagA, responsible for early steps in wall teichoic acid synthesis, had significantly reduced fitness effects in milk compared to BHI (<xref ref-type="supplementary-material" rid="SD1">Table S3</xref>). We also noted that <italic>vraX</italic>, which encodes a cell wall stress factor [<xref ref-type="bibr" rid="R61">61</xref>], was less important for growth in milk, along with other cell-wall-associated genes such as <italic>sepF, lyrA</italic> and <italic>rapZ</italic> (SAOUHSC_00787). These findings suggest that the cell wall architecture of <italic>S. aureus</italic> may be less critical for survival in milk, potentially due to the osmoprotective nature of the milk environment. This also raises questions about the efficacy of antibiotics targeting cell wall biosynthesis in mastitis treatment. Indeed, our results indicate that growth in milk confers protection against the cell wall-targeting antibiotics tunicamycin and targocil (<xref ref-type="fig" rid="F6">Fig 6A-B</xref>). Similarly, the observed reduced efficacy of penicillin G in the milk environment has been attributed to the protective effect of milk components, which may shield <italic>S. aureus</italic> from the action of the antibiotic [<xref ref-type="bibr" rid="R37">37</xref>, <xref ref-type="bibr" rid="R38">38</xref>].</p><p id="P26">In summary, our study provides important insights into the genetic factors that influence <italic>S. aureus</italic> survival and growth in milk. By identifying milk-specific determinants and linking them to antibiotic susceptibility, we offer potential new avenues for improving the treatment of mastitis. Moreover, our findings highlight the importance of considering the unique properties of the milk environment when developing antimicrobial strategies, as pathways that are essential in other media can be less critical in milk, and vice versa. Future studies could build on our findings by applying this system to other infection-relevant conditions, or to different <italic>S. aureus</italic> strains isolated from bovine mastitis cases to explore strain-specific fitness determinants associated with virulence in the milk environment.</p></sec><sec id="S12" sec-type="materials | methods"><title>Materials and Methods</title><sec id="S13"><title>Bacterial strains and growth conditions</title><p id="P27">Bacterial strains used in this study are listed in <xref ref-type="supplementary-material" rid="SD1">Table S4</xref>. <italic>S. aureus</italic> strains were grown at 37 °C in BHI medium with shaking, or on BHI agar plates. When needed, 5 μg/ml erythromycin and/or 10 μg/ml chloramphenicol were added for selection. Transformation was performed with electroporation using plasmid DNA as described before [<xref ref-type="bibr" rid="R62">62</xref>]. <italic>E. coli</italic> was grown in LB medium at 37 °C with shaking or on LA agar. Ampicillin (100 μg/ml) was added for selection. For transformation of <italic>E. coli</italic>, chemically competent cells were prepared using calcium chloride treatment, followed by transformation with heat shock according to standard protocols.</p></sec><sec id="S14"><title>Plasmid and strain construction</title><p id="P28">All plasmids used in this work are listed in <xref ref-type="supplementary-material" rid="SD1">Table S5</xref>. Primers used for cloning are listed in <xref ref-type="supplementary-material" rid="SD1">Table S6</xref>. Plasmid constructs were verified by PCR and sequencing.</p><sec id="S15"><title>Construction of pMAD-tetR-Ptet-dcas9 for chromosomal integration</title><p id="P29">The plasmid pMAD-<italic>tetR</italic>-Ptet-<italic>dcas9</italic> was constructed by Golden Gate cloning. The region upstream and downstream a neutral locus used for integration (between SAOUHSC_03046 and SAOUHSC_03047) was amplified with primer pairs mm40/mm32 and mm35/mm36, respectively, using chromosomal DNA of strain NCTC8325-4 as template. The <italic>tetR-</italic>Ptet-<italic>dcas9</italic> fragment was amplified from pFD152 [<xref ref-type="bibr" rid="R63">63</xref>] using primers mm33/mm34. All primers were designed to include BsaI restriction sites. Each PCR product was digested with BsaI-HF (New England Biolabs) and ligated into pMAD-GG using T4 DNA ligase (New England Biolabs) at a 3:1 insert-to-vector molar ratio. The ligation mix was transformed into <italic>E. coli</italic> IM08B. The resulting plasmid was verified by Sanger sequencing and transformed into electrocompetent <italic>S.aureus</italic> NCTC8325-4. Chromosomal integration of the plasmid was performed using the temperature-sensitive pMAD system., following the protocol described previously [<xref ref-type="bibr" rid="R64">64</xref>].</p></sec><sec id="S16"><title>Construction of sgRNA plasmids</title><p id="P30">Individual sgRNA plasmids were constructed by cloning a 20-bp sgRNA sequence into pVL2336 using Golden Gate cloning as described before (Liu et al., 2021). Briefly, forward and reverse oligos for each sgRNA (<xref ref-type="supplementary-material" rid="SD1">Table S6</xref>) were diluted in TEN buffer (10 mM Tris, 1 mM EDTA, 100 mM NaCl, pH8), incubated at 95 °C for 5 minutes and then slowly cooled down to room temperature for annealing. The vector, pVL2336, was digested with BsmBI. The purified vector and the annealed oligos were ligated using T4 ligase and transformed into <italic>E. coli</italic> IM08B. Correct vectors were verified by Sanger sequencing.</p></sec></sec><sec id="S17"><title>Construction of a pooled CRISPRi library in <italic>S. aureus</italic> NCTC8325-4</title><p id="P31">Plasmid isolated from the <italic>E. coli</italic> sgRNA library [<xref ref-type="bibr" rid="R21">21</xref>] were transformed into <italic>S. aureus</italic> MM267 (<italic>S. aureus</italic> NCTC8325-4, <italic>tetR</italic>-Ptet-<italic>dcas9</italic>, <italic>tetM</italic>) by electroporation. Multiple parallel transformation reactions were plated onto BHI agar with chloramphenicol selection. More than 250,000 colonies were collected using a cell scraper, pooled and resuspended in BHI with chloramphenicol selection. The pooled library was diluted to an OD<sub>600</sub> of 0.3 in BHI with chloramphenicol selection and re-grown at 37°C to an OD<sub>600</sub> of 0.8 and stored as glycerol stocks for further use.</p></sec><sec id="S18"><title>CRISPRi-seq screens</title><p id="P32">CRISPRi-seq experiments were performed following the protocol described previously [<xref ref-type="bibr" rid="R21">21</xref>] with some modifications. Briefly, the library was grown in 100 ml BHI medium or UHT milk (Tine SA, Oslo, Norway) supplemented with chloramphenicol for selection. When appropriate, 30 ng/ml aTc was added for CRISPRi induction. Four replicates per condition were used. The library was inoculated 1/1,000 from the stock, grown at 37 °C with shaking for 7 hours, then reinoculated 1/1,000 in fresh BHI or UHT milk, and grown for 6 additional hours (resulting in ~ 20 generations). For the TMP-SMX experiment, the same conditions were used, except that TMP and SMX were added to a final concentration of 0.1 μg/ml and 0.5 μg/ml, respectively.</p><p id="P33">For plasmid isolation from BHI, cells from 5 ml culture were harvested by centrifugation (4,000 x <italic>g</italic>, 5 min, 4°C) and lysed by treatment with lysozyme (0.8 mg/ml) and lysostaphin (40 μg/ml) at 37 °C for 30 minutes, followed by extraction using the E.Z.N.A.® Plasmid Mini Kit I. For plasmid isolation from milk, cells were harvested by centrifugation (7,000 x <italic>g</italic>, 5 min, 4°C). The supernatant and any remaining fat were removed, and the pellet was washed in 20% (w/v) sodium citrate until the supernatant was clear, before lysis and extraction in the same manner as samples from BHI.</p></sec><sec id="S19"><title>Library preparation and Illumina sequencing</title><p id="P34">For all CRISPRi-seq experiments, the Illumina amplicon library was prepared following previously described protocols [<xref ref-type="bibr" rid="R65">65</xref>]. Briefly, 2 μl of the plasmid was used as the template and amplified using Nextera DNA Indexes (Illumina Inc., San Diego, CA, USA) index primers. The PCR products were then purified and normalized using the SequalPrep Normalization Plate Kit (Thermo Fisher Scientific, Waltham, MA, USA). The purified libraries were quantified using the KAPA library quantification kit (KAPA Biosystems, Wilmington, MA, USA). The CRISPRi-seq experiments in milk and BHI (without TMP-SMX) were sequenced on an Illumina Miseq platform (Illumina Inc.) using the Miseq Reagent Kit v3 (Illumina Inc.), while the CRISPRi-seq with TMP-SMX was sent to Novogene (UK) for sequencing on the NovaSeq platform using 150 bp paired-end reads.</p></sec><sec id="S20"><title>CRISPRi-seq differential enrichment analyses</title><p id="P35">CRISPRi-seq differential enrichment analyses were done as previously described, with some modifications [<xref ref-type="bibr" rid="R21">21</xref>]. The read counts for each sgRNA were extracted using 2FAST2Q (v2.3.4) [<xref ref-type="bibr" rid="R66">66</xref>], with feature start position in the read set to 54. Otherwise, 2FAST2Q was used with default settings. Enrichment or depletion of sgRNAs was analyzed using DESeq2 [<xref ref-type="bibr" rid="R67">67</xref>], testing against an absolute L2FC of 1 with a significance threshold of α = 0.05. For PCA analysis, DESeq2’s blind rlog transformation was used for count normalization. Whenever L2FC are visualized or reported, these are shrunk with the apeglm method [<xref ref-type="bibr" rid="R68">68</xref>].</p><p id="P36">To account for variation in CRISPRi induction levels between TMP-SMX treated and untreated samples, we included a linear correction based on the number of generations of CRISPRi induction in the DESeq2 model. Specifically, instead of using of a binary treatment variable (induction yes/no), we included a numeric variable representing the degree of induction, by scaling and centering the number of generations of induction per treatment with the built-in R function scale(). The generation time was estimated based on CFU/ml in milk with and without TMP-SMX treatment, using 12 generations as the overall estimate for TMP-SMX treated samples, and 20 for untreated ones.</p></sec><sec id="S21"><title>Growth and antibiotic susceptibility assays</title><sec id="S22"><title>Growth curves in 96-well microtiter plates</title><p id="P37">For growth in 96-well microtiter plates, overnight cultures were diluted 1/1,000 in fresh BHI. Then, 300 μl of the diluted culture was added to each well in triplicates. OD<sub>600</sub> was measured every 10 minutes using either the Synergy H1 Hybrid Reader (BioTek) or the Hidex Sense (Hidex Oy), with 3 seconds shaking prior to each measurement. Where appropriate, chloramphenicol was added for selection, and aTc was added at 30 ng/ml for induction.</p></sec><sec id="S23"><title>Testing of CRISPRi systems in milk</title><p id="P38">CFU/ml was calculated to assess the functionality of the CRISPRi systems in milk. Overnight cultures were diluted 1/1,000 in fresh milk and incubated at 37 °C with shaking. When appropriate, erythromycin and/or chloramphenicol was added for selection, and either 30 ng/ml aTc or 500 μM IPTG was added for induction. At specific timepoints, 100 μl of 10-fold serial dilutions were plated on BHI agar containing erythromycin and/or chloramphenicol. Plates were incubated overnight at 37 °C, and CFU/ml was calculated.</p></sec><sec id="S24"><title>Susceptibility testing for TMP-SMX, targocil and tunicamycin</title><p id="P39">For susceptibility testing to TMP-SMX, targocil, and tunicamycin, overnight cultures of wild-type <italic>S. aureus</italic> NCTC8325-4 were diluted 1/1,000 in BHI and milk. Cultures were exposed to the antibiotics in a 2-fold dilution series and incubated at 37 °C for 6 hours. After incubation, 10-fold serial dilutions were prepared, and 5 μl of each dilution was spotted onto BHI agar. Plates were incubated overnight at 37 °C, and CFU/ml was calculated.</p></sec><sec id="S25"><title>Growth of individual CRISPRi strains</title><p id="P40">For the growth of individual CRISPRi strains, overnight cultures were diluted 1/1,000 in 5 ml BHI and milk and incubated at 37 °C with shaking. After 7 hours of incubation, cultures were re-diluted 1/1,000 in fresh medium and incubated for an additional 6 hours, allowing for approximately 20 generations of growth. Chloramphenicol was added for selection, and aTc (30 ng/ml) was added when appropriate for induction. TMP (0.1 mg/ml) and SMX (0.5 mg/ml) was included when necessary for susceptibility testing. After incubation, 10-fold serial dilutions of each strain were prepared, and 5 μl of each dilution was spotted on BHI agar. Plates were incubated overnight at 37 °C, and CFU/ml was calculated.</p></sec></sec></sec><sec sec-type="supplementary-material" id="SM"><title>Supplementary Material</title><supplementary-material content-type="local-data" id="SD1"><label>Supporting information (Fig S1-S2, Tables S3-S6)</label><media xlink:href="EMS199801-supplement-Supporting_information__Fig_S1_S2__Tables_S3_S6_.pdf" mimetype="application" mime-subtype="pdf" id="d14aAcEbB" position="anchor"/></supplementary-material><supplementary-material content-type="local-data" id="SD2"><label>Supporting tables S1-S2</label><media xlink:href="EMS199801-supplement-Supporting_tables_S1_S2.xlsx" mimetype="application" mime-subtype="vnd.openxmlformats-officedocument.spreadsheetml.sheet" id="d14aAcEcB" position="anchor"/></supplementary-material></sec></body><back><ack id="S26"><title>Acknowledgments</title><p>This work was supported by a Joint Programming for Antimicrobial Resistance grant to M.K. and J.-W.V. from Research Council of Norway (grant 296906) and Swiss National Science Foundation (grant 40AR40_185533), and a FRIPRO grant from Research Council of Norway to D. P (grant 314733). X.L. was supported by the National Key Research and Development Program of China (2023YFD1800100), the Science and Technology Project of Shenzhen (JCYJ20220818095602006), National Nature Science Foundation of China (82270012), and Shenzhen University 2035 Program for Excellent Research (86901-00000216). X.L. and J.-W.V. were supported by the Swiss National Science Foundation (SNSF) NCCR AntiResist 51NF40_180541.</p></ack><sec id="S27" sec-type="data-availability"><title>Data availability</title><p id="P41">All sequencing data generated in this study are available on SRA (accession number PRJNA1173950).</p></sec><ref-list><ref id="R1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sharun</surname><given-names>K</given-names></name><name><surname>Dhama</surname><given-names>K</given-names></name><name><surname>Tiwari</surname><given-names>R</given-names></name><name><surname>Gugjoo</surname><given-names>MB</given-names></name><name><surname>Iqbal Yatoo</surname><given-names>M</given-names></name><name><surname>Patel</surname><given-names>SK</given-names></name><etal/></person-group><article-title>Advances in therapeutic and managemental approaches of bovine mastitis: a comprehensive review</article-title><source>Vet Q</source><year>2021</year><volume>41</volume><issue>1</issue><fpage>107</fpage><lpage>36</lpage><pub-id pub-id-type="pmcid">PMC7906113</pub-id><pub-id pub-id-type="pmid">33509059</pub-id><pub-id pub-id-type="doi">10.1080/01652176.2021.1882713</pub-id></element-citation></ref><ref id="R2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cieza</surname><given-names>MYR</given-names></name><name><surname>Bonsaglia</surname><given-names>ECR</given-names></name><name><surname>Rall</surname><given-names>VLM</given-names></name><name><surname>Santos</surname><given-names>MVD</given-names></name><name><surname>Silva</surname><given-names>NCC</given-names></name></person-group><article-title>Staphylococcal Enterotoxins: Description and Importance in Food</article-title><source>Pathogens</source><year>2024</year><volume>13</volume><issue>8</issue><comment>Epub 20240809</comment><pub-id pub-id-type="pmcid">PMC11357529</pub-id><pub-id pub-id-type="pmid">39204276</pub-id><pub-id pub-id-type="doi">10.3390/pathogens13080676</pub-id></element-citation></ref><ref id="R3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Riva</surname><given-names>A</given-names></name><name><surname>Borghi</surname><given-names>E</given-names></name><name><surname>Cirasola</surname><given-names>D</given-names></name><name><surname>Colmegna</surname><given-names>S</given-names></name><name><surname>Borgo</surname><given-names>F</given-names></name><name><surname>Amato</surname><given-names>E</given-names></name><etal/></person-group><article-title>Methicillin-resistant <italic>Staphylococcus aureus</italic> in raw milk: prevalence, SCCmec typing, enterotoxin characterization, and antimicrobial resistance patterns</article-title><source>J Food Prot</source><year>2015</year><volume>78</volume><issue>6</issue><fpage>1142</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">26038904</pub-id></element-citation></ref><ref id="R4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sutra</surname><given-names>L</given-names></name><name><surname>Poutrel</surname><given-names>B</given-names></name></person-group><article-title>Virulence factors involved in the pathogenesis of bovine intramammary infections due to <italic>Staphylococcus aureus</italic></article-title><source>J Med Microbiol</source><year>1994</year><volume>40</volume><issue>2</issue><fpage>79</fpage><lpage>89</lpage><pub-id pub-id-type="pmid">8107066</pub-id></element-citation></ref><ref id="R5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marshall</surname><given-names>V</given-names></name><name><surname>Tamime</surname><given-names>A</given-names></name></person-group><article-title>Starter cultures employed in the manufacture of biofermented milks</article-title><source>Int J Dairy Technol</source><year>1997</year><volume>50</volume><issue>1</issue><fpage>35</fpage><lpage>41</lpage></element-citation></ref><ref id="R6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Johansson</surname><given-names>M</given-names></name><name><surname>Åkerstedt</surname><given-names>M</given-names></name><name><surname>Li</surname><given-names>S</given-names></name><name><surname>Zamaratskaia</surname><given-names>G</given-names></name><name><surname>Lundh</surname><given-names>ÅS</given-names></name></person-group><article-title>Casein breakdown in bovine milk by a field strain of <italic>Staphylococcus aureus</italic></article-title><source>J Food Protect</source><year>2013</year><volume>76</volume><issue>9</issue><fpage>1638</fpage><lpage>42</lpage><pub-id pub-id-type="pmid">23992512</pub-id></element-citation></ref><ref id="R7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Morse</surname><given-names>ML</given-names></name><name><surname>Hill</surname><given-names>KL</given-names></name><name><surname>Egan</surname><given-names>JB</given-names></name><name><surname>Hengstenberg</surname><given-names>W</given-names></name></person-group><article-title>Metabolism of lactose by <italic>Staphylococcus aureus</italic> and its genetic basis</article-title><source>J Bacteriol</source><year>1968</year><volume>95</volume><issue>6</issue><fpage>2270</fpage><lpage>4</lpage><pub-id pub-id-type="pmcid">PMC315162</pub-id><pub-id pub-id-type="pmid">5669899</pub-id><pub-id pub-id-type="doi">10.1128/jb.95.6.2270-2274.1968</pub-id></element-citation></ref><ref id="R8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sandgren</surname><given-names>CH</given-names></name><name><surname>Mamo</surname><given-names>W</given-names></name><name><surname>Larsson</surname><given-names>I</given-names></name><name><surname>Lindahl</surname><given-names>M</given-names></name><name><surname>Björk</surname><given-names>I</given-names></name></person-group><article-title>A periodate-sensitive anti-phagocytic surface structure, induced by growth in milk whey, on <italic>Staphylococcus aureus</italic> isolated from bovine mastitis</article-title><source>Microb Pathog</source><year>1991</year><volume>11</volume><issue>3</issue><fpage>211</fpage><lpage>20</lpage><pub-id pub-id-type="pmid">1666171</pub-id></element-citation></ref><ref id="R9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sutra</surname><given-names>L</given-names></name><name><surname>Rainard</surname><given-names>P</given-names></name><name><surname>Poutrel</surname><given-names>B</given-names></name></person-group><article-title>Phagocytosis of mastitis isolates of <italic>Staphylococcus aureus</italic> and expression of type 5 capsular polysaccharide are influenced by growth in the presence of milk</article-title><source>J Clin Microbiol</source><year>1990</year><volume>28</volume><issue>10</issue><fpage>2253</fpage><lpage>8</lpage><pub-id pub-id-type="pmcid">PMC268157</pub-id><pub-id pub-id-type="pmid">2229349</pub-id><pub-id pub-id-type="doi">10.1128/jcm.28.10.2253-2258.1990</pub-id></element-citation></ref><ref id="R10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vrieling</surname><given-names>M</given-names></name><name><surname>Boerhout</surname><given-names>EM</given-names></name><name><surname>van Wigcheren</surname><given-names>GF</given-names></name><name><surname>Koymans</surname><given-names>KJ</given-names></name><name><surname>Mols-Vorstermans</surname><given-names>TG</given-names></name><name><surname>de Haas</surname><given-names>CJC</given-names></name><etal/></person-group><article-title>LukMF’ is the major secreted leukocidin of bovine S<italic>taphylococcus aureus</italic> and is produced in vivo during bovine mastitis</article-title><source>Sci Rep</source><year>2016</year><volume>6</volume><issue>1</issue><elocation-id>37759</elocation-id><pub-id pub-id-type="pmcid">PMC5123576</pub-id><pub-id pub-id-type="pmid">27886237</pub-id><pub-id pub-id-type="doi">10.1038/srep37759</pub-id></element-citation></ref><ref id="R11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lammers</surname><given-names>A</given-names></name><name><surname>Kruijt</surname><given-names>E</given-names></name><name><surname>van de Kuijt</surname><given-names>C</given-names></name><name><surname>Nuijten</surname><given-names>PJM</given-names></name><name><surname>Smith</surname><given-names>HE</given-names></name></person-group><article-title>Identification of <italic>Staphylococcus aureus</italic> genes expressed during growth in milk: a useful model for selection of genes important in bovine mastitis?</article-title><source>Microbiology</source><year>2000</year><volume>146</volume><issue>4</issue><fpage>981</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">10784056</pub-id></element-citation></ref><ref id="R12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sharer</surname><given-names>MV</given-names></name><name><surname>Su</surname><given-names>C</given-names></name><name><surname>Hegde</surname><given-names>NV</given-names></name><name><surname>Jayarao</surname><given-names>BM</given-names></name><name><surname>Sordillo</surname><given-names>LM</given-names></name></person-group><article-title>Differential expression of the lactose transporter gene affects growth of <italic>Staphylococcus aureus</italic> in milk</article-title><source>J Dairy Sci</source><year>2003</year><volume>86</volume><issue>7</issue><fpage>2373</fpage><lpage>81</lpage><pub-id pub-id-type="pmid">12906055</pub-id></element-citation></ref><ref id="R13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xue</surname><given-names>T</given-names></name><name><surname>Chen</surname><given-names>X</given-names></name><name><surname>Shang</surname><given-names>F</given-names></name></person-group><article-title>Short communication: Effects of lactose and milk on the expression of biofilm-associated genes in <italic>Staphylococcus aureus</italic> strains isolated from a dairy cow with mastitis</article-title><source>J Dairy Sci</source><year>2014</year><volume>97</volume><issue>10</issue><fpage>6129</fpage><lpage>34</lpage><pub-id pub-id-type="pmid">25151886</pub-id></element-citation></ref><ref id="R14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kolar</surname><given-names>SL</given-names></name><name><surname>Ibarra</surname><given-names>JA</given-names></name><name><surname>Rivera</surname><given-names>FE</given-names></name><name><surname>Mootz</surname><given-names>JM</given-names></name><name><surname>Davenport</surname><given-names>JE</given-names></name><name><surname>Stevens</surname><given-names>SM</given-names></name><etal/></person-group><article-title>Extracellular proteases are key mediators of <italic>Staphylococcus aureus</italic> virulence via the global modulation of virulence-determinant stability</article-title><source>Microbiologyopen</source><year>2013</year><volume>2</volume><issue>1</issue><fpage>18</fpage><lpage>34</lpage><comment>Epub 20121211</comment><pub-id pub-id-type="pmcid">PMC3584211</pub-id><pub-id pub-id-type="pmid">23233325</pub-id><pub-id pub-id-type="doi">10.1002/mbo3.55</pub-id></element-citation></ref><ref id="R15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saeed</surname><given-names>SI</given-names></name><name><surname>Kamaruzzaman</surname><given-names>NF</given-names></name><name><surname>Gahamanyi</surname><given-names>N</given-names></name><name><surname>Nguyen</surname><given-names>TTH</given-names></name><name><surname>Hossain</surname><given-names>D</given-names></name><name><surname>Kahwa</surname><given-names>I</given-names></name></person-group><article-title>Confronting the complexities of antimicrobial management for <italic>Staphylococcus aureus</italic> causing bovine mastitis: an innovative paradigm</article-title><source>Ir Vet J</source><year>2024</year><volume>77</volume><issue>1</issue><fpage>4</fpage><pub-id pub-id-type="pmcid">PMC10900600</pub-id><pub-id pub-id-type="pmid">38418988</pub-id><pub-id pub-id-type="doi">10.1186/s13620-024-00264-1</pub-id></element-citation></ref><ref id="R16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Molineri</surname><given-names>AI</given-names></name><name><surname>Camussone</surname><given-names>C</given-names></name><name><surname>Zbrun</surname><given-names>MV</given-names></name><name><surname>Suárez Archilla</surname><given-names>G</given-names></name><name><surname>Cristiani</surname><given-names>M</given-names></name><name><surname>Neder</surname><given-names>V</given-names></name><etal/></person-group><article-title>Antimicrobial resistance of <italic>Staphylococcus aureus</italic> isolated from bovine mastitis: systematic review and meta-analysis</article-title><source>Prev Vet Med</source><year>2021</year><volume>188</volume><elocation-id>105261</elocation-id><pub-id pub-id-type="pmid">33508662</pub-id></element-citation></ref><ref id="R17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rana</surname><given-names>EA</given-names></name><name><surname>Fazal</surname><given-names>MA</given-names></name><name><surname>Alim</surname><given-names>MA</given-names></name></person-group><article-title>Frequently used therapeutic antimicrobials and their resistance patterns on <italic>Staphylococcus aureus</italic> and <italic>Escherichia coli</italic> in mastitis affected lactating cows</article-title><source>Int J Vet Sci Med</source><year>2022</year><volume>10</volume><issue>1</issue><fpage>1</fpage><lpage>10</lpage><comment>Epub 20220228</comment><pub-id pub-id-type="pmcid">PMC8890510</pub-id><pub-id pub-id-type="pmid">35291582</pub-id><pub-id pub-id-type="doi">10.1080/23144599.2022.2038494</pub-id></element-citation></ref><ref id="R18"><label>18</label><element-citation publication-type="web"><collab>Legemiddelverket</collab><source>Terapianbefaling - bruk av antibakterielle midler til matproduserende dyr Statens Legemiddelverk2022</source><comment>[updated 19.06.2023; cited 2024]. Available from: <ext-link ext-link-type="uri" xlink:href="https://www.dmp.no/veterinermedisin/terapianbefalinger/bruk-av-antibakterielle-midler-til-matproduserende-dyr">https://www.dmp.no/veterinermedisin/terapianbefalinger/bruk-av-antibakterielle-midler-til-matproduserende-dyr</ext-link></comment></element-citation></ref><ref id="R19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jin</surname><given-names>Q</given-names></name><name><surname>Xie</surname><given-names>X</given-names></name><name><surname>Zhai</surname><given-names>Y</given-names></name><name><surname>Zhang</surname><given-names>H</given-names></name></person-group><article-title>Mechanisms of folate metabolism-related substances affecting <italic>Staphylococcus aureus</italic> infection</article-title><source>Int J Med Microbiol</source><year>2023</year><volume>313</volume><issue>2</issue><elocation-id>151577</elocation-id><pub-id pub-id-type="pmid">36841056</pub-id></element-citation></ref><ref id="R20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rainard</surname><given-names>P</given-names></name><name><surname>Foucras</surname><given-names>G</given-names></name><name><surname>Fitzgerald</surname><given-names>JR</given-names></name><name><surname>Watts</surname><given-names>JL</given-names></name><name><surname>Koop</surname><given-names>G</given-names></name><name><surname>Middleton</surname><given-names>JR</given-names></name></person-group><article-title>Knowledge gaps and research priorities in <italic>Staphylococcus aureus</italic> mastitis control</article-title><source>Transbound Emerg Dis</source><year>2018</year><volume>65 Suppl 1</volume><fpage>149</fpage><lpage>65</lpage><comment>Epub 20171006</comment><pub-id pub-id-type="pmid">28984427</pub-id></element-citation></ref><ref id="R21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>X</given-names></name><name><surname>de Bakker</surname><given-names>V</given-names></name><name><surname>Heggenhougen</surname><given-names>MV</given-names></name><name><surname>Mårli</surname><given-names>MT</given-names></name><name><surname>Frøynes</surname><given-names>AH</given-names></name><name><surname>Salehian</surname><given-names>Z</given-names></name><etal/></person-group><article-title>Genome-wide CRISPRi screens for high-throughput fitness quantification and identification of determinants for dalbavancin susceptibility in <italic>Staphylococcus aureus</italic></article-title><source>mSystems</source><year>2024</year><elocation-id>e0128923</elocation-id><comment>Epub 20240605</comment><pub-id pub-id-type="pmcid">PMC11265419</pub-id><pub-id pub-id-type="pmid">38837392</pub-id><pub-id pub-id-type="doi">10.1128/msystems.01289-23</pub-id></element-citation></ref><ref id="R22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reed</surname><given-names>P</given-names></name><name><surname>Sorg</surname><given-names>M</given-names></name><name><surname>Alwardt</surname><given-names>D</given-names></name><name><surname>Serra</surname><given-names>L</given-names></name><name><surname>Veiga</surname><given-names>H</given-names></name><name><surname>Schäper</surname><given-names>S</given-names></name><etal/></person-group><article-title>A CRISPRi-based genetic resource to study essential <italic>Staphylococcus aureus</italic> genes</article-title><source>mBio</source><year>2024</year><volume>15</volume><issue>1</issue><elocation-id>e0277323</elocation-id><comment>Epub 20231206</comment><pub-id pub-id-type="pmcid">PMC10870820</pub-id><pub-id pub-id-type="pmid">38054745</pub-id><pub-id pub-id-type="doi">10.1128/mbio.02773-23</pub-id></element-citation></ref><ref id="R23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>de Bakker</surname><given-names>V</given-names></name><name><surname>Liu</surname><given-names>X</given-names></name><name><surname>Bravo</surname><given-names>AM</given-names></name><name><surname>Veening</surname><given-names>JW</given-names></name></person-group><article-title>CRISPRi-seq for genome-wide fitness quantification in bacteria</article-title><source>Nat Protoc</source><year>2022</year><volume>17</volume><issue>2</issue><fpage>252</fpage><lpage>81</lpage><comment>Epub 20220107</comment><pub-id pub-id-type="pmid">34997243</pub-id></element-citation></ref><ref id="R24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fuchs</surname><given-names>S</given-names></name><name><surname>Mehlan</surname><given-names>H</given-names></name><name><surname>Bernhardt</surname><given-names>J</given-names></name><name><surname>Hennig</surname><given-names>A</given-names></name><name><surname>Michalik</surname><given-names>S</given-names></name><name><surname>Surmann</surname><given-names>K</given-names></name><etal/></person-group><article-title>AureoWiki - The repository of the <italic>Staphylococcus aureus</italic> research and annotation community</article-title><source>Int J Med Microbiol</source><year>2018</year><volume>308</volume><issue>6</issue><fpage>558</fpage><lpage>68</lpage><pub-id pub-id-type="pmid">29198880</pub-id></element-citation></ref><ref id="R25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Masters</surname><given-names>PA</given-names></name><name><surname>O’Bryan</surname><given-names>TA</given-names></name><name><surname>Zurlo</surname><given-names>J</given-names></name><name><surname>Miller</surname><given-names>DQ</given-names></name><name><surname>Joshi</surname><given-names>N</given-names></name></person-group><article-title>Trimethoprim-sulfamethoxazole revisited</article-title><source>Arch Intern Med</source><year>2003</year><volume>163</volume><issue>4</issue><fpage>402</fpage><lpage>10</lpage><pub-id pub-id-type="pmid">12588198</pub-id></element-citation></ref><ref id="R26"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sato</surname><given-names>T</given-names></name><name><surname>Ito</surname><given-names>R</given-names></name><name><surname>Kawamura</surname><given-names>M</given-names></name><name><surname>Fujimura</surname><given-names>S</given-names></name></person-group><article-title>The risk of emerging resistance to trimethoprim/sulfamethoxazole in <italic>Staphylococcus aureus</italic></article-title><source>Infect Drug Resist</source><year>2022</year><volume>15</volume><fpage>4779</fpage><lpage>84</lpage><pub-id pub-id-type="pmcid">PMC9419895</pub-id><pub-id pub-id-type="pmid">36039323</pub-id><pub-id pub-id-type="doi">10.2147/IDR.S375588</pub-id></element-citation></ref><ref id="R27"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kriegeskorte</surname><given-names>A</given-names></name><name><surname>Block</surname><given-names>D</given-names></name><name><surname>Drescher</surname><given-names>M</given-names></name><name><surname>Windmüller</surname><given-names>N</given-names></name><name><surname>Mellmann</surname><given-names>A</given-names></name><name><surname>Baum</surname><given-names>C</given-names></name><etal/></person-group><article-title>Inactivation of <italic>thyA</italic> in <italic>Staphylococcus aureus</italic> attenuates virulence and has a strong impact on metabolism and virulence gene expression</article-title><source>mBio</source><year>2014</year><volume>5</volume><issue>4</issue><elocation-id>e01447-14</elocation-id><comment>Epub 20140729</comment><pub-id pub-id-type="pmcid">PMC4128360</pub-id><pub-id pub-id-type="pmid">25073642</pub-id><pub-id pub-id-type="doi">10.1128/mBio.01447-14</pub-id></element-citation></ref><ref id="R28"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ha</surname><given-names>KP</given-names></name><name><surname>Edwards</surname><given-names>AM</given-names></name></person-group><article-title>DNA Repair in <italic>Staphylococcus aureus</italic></article-title><source>Microbiol Mol Biol Rev</source><year>2021</year><volume>85</volume><issue>4</issue><elocation-id>e0009121</elocation-id><comment>Epub 20210915</comment><pub-id pub-id-type="pmcid">PMC8483670</pub-id><pub-id pub-id-type="pmid">34523959</pub-id><pub-id pub-id-type="doi">10.1128/MMBR.00091-21</pub-id></element-citation></ref><ref id="R29"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pang</surname><given-names>T</given-names></name><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Lim</surname><given-names>HC</given-names></name><name><surname>Bernhardt</surname><given-names>TG</given-names></name><name><surname>Rudner</surname><given-names>DZ</given-names></name></person-group><article-title>The nucleoid occlusion factor Noc controls DNA replication initiation in <italic>Staphylococcus aureus</italic></article-title><source>PLoS Genet</source><year>2017</year><volume>13</volume><issue>7</issue><elocation-id>e1006908</elocation-id><comment>Epub 20170719</comment><pub-id pub-id-type="pmcid">PMC5540599</pub-id><pub-id pub-id-type="pmid">28723932</pub-id><pub-id pub-id-type="doi">10.1371/journal.pgen.1006908</pub-id></element-citation></ref><ref id="R30"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Campbell</surname><given-names>J</given-names></name><name><surname>Singh</surname><given-names>AK</given-names></name><name><surname>Santa Maria</surname><given-names>JP</given-names><suffix>Jr</suffix></name><name><surname>Kim</surname><given-names>Y</given-names></name><name><surname>Brown</surname><given-names>S</given-names></name><name><surname>Swoboda</surname><given-names>JG</given-names></name><etal/></person-group><article-title>Synthetic lethal compound combinations reveal a fundamental connection between wall teichoic acid and peptidoglycan biosyntheses in <italic>Staphylococcus aureus</italic></article-title><source>ACS Chem Biol</source><year>2011</year><volume>6</volume><issue>1</issue><fpage>106</fpage><lpage>16</lpage><comment>Epub 20101104</comment><pub-id pub-id-type="pmcid">PMC3025082</pub-id><pub-id pub-id-type="pmid">20961110</pub-id><pub-id pub-id-type="doi">10.1021/cb100269f</pub-id></element-citation></ref><ref id="R31"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>H</given-names></name><name><surname>Gill</surname><given-names>CJ</given-names></name><name><surname>Lee</surname><given-names>SH</given-names></name><name><surname>Mann</surname><given-names>P</given-names></name><name><surname>Zuck</surname><given-names>P</given-names></name><name><surname>Meredith</surname><given-names>TC</given-names></name><etal/></person-group><article-title>Discovery of wall teichoic acid inhibitors as potential anti-MRSA β-lactam combination agents</article-title><source>Chem Biol</source><year>2013</year><volume>20</volume><issue>2</issue><fpage>272</fpage><lpage>84</lpage><pub-id pub-id-type="pmcid">PMC3762323</pub-id><pub-id pub-id-type="pmid">23438756</pub-id><pub-id pub-id-type="doi">10.1016/j.chembiol.2012.11.013</pub-id></element-citation></ref><ref id="R32"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yee</surname><given-names>R</given-names></name><name><surname>Cui</surname><given-names>P</given-names></name><name><surname>Shi</surname><given-names>W</given-names></name><name><surname>Feng</surname><given-names>J</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name></person-group><article-title>Genetic Screen Reveals the Role of Purine Metabolism in <italic>Staphylococcus aureus</italic> Persistence to Rifampicin</article-title><source>Antibiotics</source><year>2015</year><volume>4</volume><issue>4</issue><fpage>627</fpage><lpage>42</lpage><pub-id pub-id-type="pmcid">PMC4790316</pub-id><pub-id pub-id-type="pmid">27025643</pub-id><pub-id pub-id-type="doi">10.3390/antibiotics4040627</pub-id></element-citation></ref><ref id="R33"><label>33</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sause</surname><given-names>WE</given-names></name><name><surname>Balasubramanian</surname><given-names>D</given-names></name><name><surname>Irnov</surname><given-names>I</given-names></name><name><surname>Copin</surname><given-names>R</given-names></name><name><surname>Sullivan</surname><given-names>MJ</given-names></name><name><surname>Sommerfield</surname><given-names>A</given-names></name><etal/></person-group><article-title>The purine biosynthesis regulator PurR moonlights as a virulence regulator in <italic>Staphylococcus aureus</italic></article-title><source>Proc Natl Acad Sci U S A</source><year>2019</year><volume>116</volume><issue>27</issue><fpage>13563</fpage><lpage>72</lpage><comment>Epub 20190619</comment><pub-id pub-id-type="pmcid">PMC6613142</pub-id><pub-id pub-id-type="pmid">31217288</pub-id><pub-id pub-id-type="doi">10.1073/pnas.1904280116</pub-id></element-citation></ref><ref id="R34"><label>34</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goncheva</surname><given-names>MI</given-names></name><name><surname>Flannagan</surname><given-names>RS</given-names></name><name><surname>Sterling</surname><given-names>BE</given-names></name><name><surname>Laakso</surname><given-names>HA</given-names></name><name><surname>Friedrich</surname><given-names>NC</given-names></name><name><surname>Kaiser</surname><given-names>JC</given-names></name><etal/></person-group><article-title>Stress-induced inactivation of the <italic>Staphylococcus aureus</italic> purine biosynthesis repressor leads to hypervirulence</article-title><source>Nat Commun</source><year>2019</year><volume>10</volume><issue>1</issue><fpage>775</fpage><pub-id pub-id-type="pmcid">PMC6377658</pub-id><pub-id pub-id-type="pmid">30770821</pub-id><pub-id pub-id-type="doi">10.1038/s41467-019-08724-x</pub-id></element-citation></ref><ref id="R35"><label>35</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goncheva</surname><given-names>MI</given-names></name><name><surname>Flannagan</surname><given-names>RS</given-names></name><name><surname>Heinrichs</surname><given-names>DE</given-names></name></person-group><article-title>De Novo Purine Biosynthesis Is Required for Intracellular Growth of <italic>Staphylococcus aureus</italic> and for the Hypervirulence Phenotype of a purR Mutant</article-title><source>Infect Immun</source><year>2020</year><volume>88</volume><issue>5</issue><comment>Epub 20200420</comment><pub-id pub-id-type="pmcid">PMC7171247</pub-id><pub-id pub-id-type="pmid">32094249</pub-id><pub-id pub-id-type="doi">10.1128/IAI.00104-20</pub-id></element-citation></ref><ref id="R36"><label>36</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chin</surname><given-names>D</given-names></name><name><surname>Goncheva</surname><given-names>MI</given-names></name><name><surname>Flannagan</surname><given-names>RS</given-names></name><name><surname>Deecker</surname><given-names>SR</given-names></name><name><surname>Guariglia-Oropeza</surname><given-names>V</given-names></name><name><surname>Ensminger</surname><given-names>AW</given-names></name><etal/></person-group><article-title>Coagulase-negative staphylococci release a purine analog that inhibits <italic>Staphylococcus aureus</italic> virulence</article-title><source>Nat Commun</source><year>2021</year><volume>12</volume><issue>1</issue><elocation-id>1887</elocation-id><comment>Epub 20210325</comment><pub-id pub-id-type="pmcid">PMC7994395</pub-id><pub-id pub-id-type="pmid">33767207</pub-id><pub-id pub-id-type="doi">10.1038/s41467-021-22175-3</pub-id></element-citation></ref><ref id="R37"><label>37</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ali-Vehmas</surname><given-names>T</given-names></name><name><surname>Westphalen</surname><given-names>P</given-names></name><name><surname>Myllys</surname><given-names>V</given-names></name><name><surname>Sandholm</surname><given-names>M</given-names></name></person-group><article-title>Binding of <italic>Staphylococcus aureus</italic> to milk fat globules increases resistance to penicillin-G</article-title><source>J Dairy Res</source><year>1997</year><volume>64</volume><issue>2</issue><fpage>253</fpage><lpage>60</lpage><pub-id pub-id-type="pmid">9161917</pub-id></element-citation></ref><ref id="R38"><label>38</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Winther</surname><given-names>AR</given-names></name><name><surname>Perrin</surname><given-names>A</given-names></name><name><surname>Nordraak</surname><given-names>AOO</given-names></name><name><surname>Kjos</surname><given-names>M</given-names></name><name><surname>Porcellato</surname><given-names>D</given-names></name></person-group><article-title>An in vitro evaluation of the effect of antimicrobial treatment on bovine mammary microbiota</article-title><source>Sci Rep</source><year>2024</year><volume>14</volume><issue>1</issue><elocation-id>18333</elocation-id><pub-id pub-id-type="pmcid">PMC11306798</pub-id><pub-id pub-id-type="pmid">39112607</pub-id><pub-id pub-id-type="doi">10.1038/s41598-024-69273-y</pub-id></element-citation></ref><ref id="R39"><label>39</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Leonard</surname><given-names>SN</given-names></name><name><surname>Kaatz</surname><given-names>GW</given-names></name><name><surname>Rucker</surname><given-names>LR</given-names></name><name><surname>Rybak</surname><given-names>MJ</given-names></name></person-group><article-title>Synergy between gemifloxacin and trimethoprim/sulfamethoxazole against community-associated methicillin-resistant <italic>Staphylococcus aureus</italic></article-title><source>J Antimicrob Chemother</source><year>2008</year><volume>62</volume><issue>6</issue><fpage>1305</fpage><lpage>10</lpage><comment>Epub 20080918</comment><pub-id pub-id-type="pmid">18801920</pub-id></element-citation></ref><ref id="R40"><label>40</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cassat</surname><given-names>JE</given-names></name><name><surname>Skaar</surname><given-names>EP</given-names></name></person-group><article-title>Metal ion acquisition in <italic>Staphylococcus aureus</italic>: overcoming nutritional immunity</article-title><source>Semin Immunopathol</source><year>2012</year><volume>34</volume><issue>2</issue><fpage>215</fpage><lpage>35</lpage><pub-id pub-id-type="pmcid">PMC3796439</pub-id><pub-id pub-id-type="pmid">22048835</pub-id><pub-id pub-id-type="doi">10.1007/s00281-011-0294-4</pub-id></element-citation></ref><ref id="R41"><label>41</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hammer</surname><given-names>ND</given-names></name><name><surname>Skaar</surname><given-names>EP</given-names></name></person-group><article-title>Molecular mechanisms of <italic>Staphylococcus aureus</italic> iron acquisition</article-title><source>Annu Rev Microbiol</source><year>2011</year><volume>65</volume><fpage>129</fpage><lpage>47</lpage><pub-id pub-id-type="pmcid">PMC3807827</pub-id><pub-id pub-id-type="pmid">21639791</pub-id><pub-id pub-id-type="doi">10.1146/annurev-micro-090110-102851</pub-id></element-citation></ref><ref id="R42"><label>42</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kehl-Fie</surname><given-names>TE</given-names></name><name><surname>Skaar</surname><given-names>EP</given-names></name></person-group><article-title>Nutritional immunity beyond iron: a role for manganese and zinc</article-title><source>Curr Opin Chem Biol</source><year>2010</year><volume>14</volume><issue>2</issue><fpage>218</fpage><lpage>24</lpage><comment>Epub 20091216</comment><pub-id pub-id-type="pmcid">PMC2847644</pub-id><pub-id pub-id-type="pmid">20015678</pub-id><pub-id pub-id-type="doi">10.1016/j.cbpa.2009.11.008</pub-id></element-citation></ref><ref id="R43"><label>43</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carlson</surname><given-names>SK</given-names></name><name><surname>Erickson</surname><given-names>DL</given-names></name><name><surname>Wilson</surname><given-names>E</given-names></name></person-group><article-title><italic>Staphylococcus aureus</italic> metal acquisition in the mastitic mammary gland</article-title><source>Microb Pathog</source><year>2020</year><volume>144</volume><elocation-id>104179</elocation-id><pub-id pub-id-type="pmid">32244043</pub-id></element-citation></ref><ref id="R44"><label>44</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lönnerdal</surname><given-names>B</given-names></name><name><surname>Keen</surname><given-names>CL</given-names></name><name><surname>Hurley</surname><given-names>LS</given-names></name></person-group><article-title>Iron, copper, zinc, and manganese in milk</article-title><source>Annu Rev Nutr</source><year>1981</year><volume>1</volume><fpage>149</fpage><lpage>74</lpage><comment>volume 1, 1981</comment><pub-id pub-id-type="pmid">6764714</pub-id></element-citation></ref><ref id="R45"><label>45</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Beasley</surname><given-names>FC</given-names></name><name><surname>Vinés</surname><given-names>ED</given-names></name><name><surname>Grigg</surname><given-names>JC</given-names></name><name><surname>Zheng</surname><given-names>Q</given-names></name><name><surname>Liu</surname><given-names>S</given-names></name><name><surname>Lajoie</surname><given-names>GA</given-names></name><etal/></person-group><article-title>Characterization of staphyloferrin A biosynthetic and transport mutants in <italic>Staphylococcus aureus</italic></article-title><source>Mol Microbiol</source><year>2009</year><volume>72</volume><issue>4</issue><fpage>947</fpage><lpage>63</lpage><comment>Epub 20090414</comment><pub-id pub-id-type="pmid">19400778</pub-id></element-citation></ref><ref id="R46"><label>46</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dale</surname><given-names>SE</given-names></name><name><surname>Sebulsky</surname><given-names>MT</given-names></name><name><surname>Heinrichs</surname><given-names>DE</given-names></name></person-group><article-title>Involvement of SirABC in iron-siderophore import in <italic>Staphylococcus aureus</italic></article-title><source>J Bacteriol</source><year>2004</year><volume>186</volume><issue>24</issue><fpage>8356</fpage><lpage>62</lpage><pub-id pub-id-type="pmcid">PMC532444</pub-id><pub-id pub-id-type="pmid">15576785</pub-id><pub-id pub-id-type="doi">10.1128/JB.186.24.8356-8362.2004</pub-id></element-citation></ref><ref id="R47"><label>47</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kehl-Fie</surname><given-names>TE</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Moore</surname><given-names>JL</given-names></name><name><surname>Farrand</surname><given-names>AJ</given-names></name><name><surname>Hood</surname><given-names>MI</given-names></name><name><surname>Rathi</surname><given-names>S</given-names></name><etal/></person-group><article-title>MntABC and MntH contribute to systemic <italic>Staphylococcus aureus</italic> infection by competing with calprotectin for nutrient manganese</article-title><source>Infect Immun</source><year>2013</year><volume>81</volume><issue>9</issue><fpage>3395</fpage><lpage>405</lpage><comment>Epub 20130701</comment><pub-id pub-id-type="pmcid">PMC3754211</pub-id><pub-id pub-id-type="pmid">23817615</pub-id><pub-id pub-id-type="doi">10.1128/IAI.00420-13</pub-id></element-citation></ref><ref id="R48"><label>48</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Diarra</surname><given-names>MS</given-names></name><name><surname>Petitclerc</surname><given-names>D</given-names></name><name><surname>Deschênes</surname><given-names>É</given-names></name><name><surname>Lessard</surname><given-names>N</given-names></name><name><surname>Grondin</surname><given-names>G</given-names></name><name><surname>Talbot</surname><given-names>BG</given-names></name><etal/></person-group><article-title>Lactoferrin against <italic>Staphylococcus aureus</italic> mastitis: Lactoferrin alone or in combination with penicillin G on bovine polymorphonuclear function and mammary epithelial cells colonisation by <italic>Staphylococcus aureus</italic></article-title><source>Vet Immunol Immunopathol</source><year>2003</year><volume>95</volume><issue>1</issue><fpage>33</fpage><lpage>42</lpage><pub-id pub-id-type="pmid">12969634</pub-id></element-citation></ref><ref id="R49"><label>49</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Diarra</surname><given-names>MS</given-names></name><name><surname>Petitclerc</surname><given-names>D</given-names></name><name><surname>Lacasse</surname><given-names>P</given-names></name></person-group><article-title>Effect of lactoferrin in combination with penicillin on the morphology and the physiology of <italic>Staphylococcus aureus</italic> isolated from bovine mastitis1, 2</article-title><source>J Dairy Sci</source><year>2002</year><volume>85</volume><issue>5</issue><fpage>1141</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">12086049</pub-id></element-citation></ref><ref id="R50"><label>50</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kai</surname><given-names>K</given-names></name><name><surname>Komine</surname><given-names>Y</given-names></name><name><surname>Komine</surname><given-names>K-i</given-names></name><name><surname>Asai</surname><given-names>K-i</given-names></name><name><surname>Kuroishi</surname><given-names>T</given-names></name><name><surname>Kozutsumi</surname><given-names>T</given-names></name><etal/></person-group><article-title>Effects of bovine lactoferrin by the intramammary infusion in cows with staphylococcal mastitis during the early non-lactating period</article-title><source>J Vet Med Sci</source><year>2002</year><volume>64</volume><issue>10</issue><fpage>873</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">12419862</pub-id></element-citation></ref><ref id="R51"><label>51</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cheung</surname><given-names>AL</given-names></name><name><surname>Nishina</surname><given-names>KA</given-names></name><name><surname>Trotonda</surname><given-names>MP</given-names></name><name><surname>Tamber</surname><given-names>S</given-names></name></person-group><article-title>The SarA protein family of <italic>Staphylococcus aureus</italic></article-title><source>Int J Biochem Cell Biol</source><year>2008</year><volume>40</volume><issue>3</issue><fpage>355</fpage><lpage>61</lpage><comment>Epub 20071113</comment><pub-id pub-id-type="pmcid">PMC2274939</pub-id><pub-id pub-id-type="pmid">18083623</pub-id><pub-id pub-id-type="doi">10.1016/j.biocel.2007.10.032</pub-id></element-citation></ref><ref id="R52"><label>52</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cheung</surname><given-names>AL</given-names></name><name><surname>Koomey</surname><given-names>JM</given-names></name><name><surname>Butler</surname><given-names>CA</given-names></name><name><surname>Projan</surname><given-names>SJ</given-names></name><name><surname>Fischetti</surname><given-names>VA</given-names></name></person-group><article-title>Regulation of exoprotein expression in <italic>Staphylococcus aureus</italic> by a locus (<italic>sar</italic>) distinct from <italic>agr</italic></article-title><source>Proc Natl Acad Sci U S A</source><year>1992</year><volume>89</volume><issue>14</issue><fpage>6462</fpage><lpage>6</lpage><pub-id pub-id-type="pmcid">PMC49521</pub-id><pub-id pub-id-type="pmid">1321441</pub-id><pub-id pub-id-type="doi">10.1073/pnas.89.14.6462</pub-id></element-citation></ref><ref id="R53"><label>53</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cheung</surname><given-names>AL</given-names></name><name><surname>Bayer</surname><given-names>AS</given-names></name><name><surname>Zhang</surname><given-names>G</given-names></name><name><surname>Gresham</surname><given-names>H</given-names></name><name><surname>Xiong</surname><given-names>Y-Q</given-names></name></person-group><article-title>Regulation of virulence determinants <italic>in vitro</italic> and <italic>in vivo</italic> in <italic>Staphylococcus aureus</italic></article-title><source>FEMS Immunol Med Microbiol</source><year>2004</year><volume>40</volume><issue>1</issue><fpage>1</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">14734180</pub-id></element-citation></ref><ref id="R54"><label>54</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oriol</surname><given-names>C</given-names></name><name><surname>Cengher</surname><given-names>L</given-names></name><name><surname>Manna</surname><given-names>AC</given-names></name><name><surname>Mauro</surname><given-names>T</given-names></name><name><surname>Pinel-Marie</surname><given-names>ML</given-names></name><name><surname>Felden</surname><given-names>B</given-names></name><etal/></person-group><article-title>Expanding the <italic>Staphylococcus aureus</italic> SarA regulon to small RNAs</article-title><source>mSystems</source><year>2021</year><volume>6</volume><issue>5</issue><elocation-id>e0071321</elocation-id><comment>Epub 20211012</comment><pub-id pub-id-type="pmcid">PMC8510525</pub-id><pub-id pub-id-type="pmid">34636666</pub-id><pub-id pub-id-type="doi">10.1128/mSystems.00713-21</pub-id></element-citation></ref><ref id="R55"><label>55</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chien</surname><given-names>Y-t</given-names></name><name><surname>Manna</surname><given-names>AC</given-names></name><name><surname>Cheung</surname><given-names>AL</given-names></name></person-group><article-title>SarA level is a determinant of <italic>agr</italic> activation in <italic>Staphylococcus aureus</italic></article-title><source>Mol Microbiol</source><year>1998</year><volume>30</volume><issue>5</issue><fpage>991</fpage><lpage>1001</lpage><pub-id pub-id-type="pmid">9988476</pub-id></element-citation></ref><ref id="R56"><label>56</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Manna</surname><given-names>AC</given-names></name><name><surname>Ingavale</surname><given-names>SS</given-names></name><name><surname>Maloney</surname><given-names>M</given-names></name><name><surname>van Wamel</surname><given-names>W</given-names></name><name><surname>Cheung</surname><given-names>AL</given-names></name></person-group><article-title>Identification of sarV (SA2062), a new transcriptional regulator, is repressed by SarA and MgrA (SA0641) and involved in the regulation of autolysis in <italic>Staphylococcus aureus</italic></article-title><source>J Bacteriol</source><year>2004</year><volume>186</volume><issue>16</issue><fpage>5267</fpage><lpage>80</lpage><pub-id pub-id-type="pmcid">PMC490931</pub-id><pub-id pub-id-type="pmid">15292128</pub-id><pub-id pub-id-type="doi">10.1128/JB.186.16.5267-5280.2004</pub-id></element-citation></ref><ref id="R57"><label>57</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cheung</surname><given-names>AL</given-names></name><name><surname>Schmidt</surname><given-names>K</given-names></name><name><surname>Bateman</surname><given-names>B</given-names></name><name><surname>Manna</surname><given-names>AC</given-names></name></person-group><article-title>SarS, a SarA homolog repressible by <italic>agr</italic>, is an activator of protein A synthesis in <italic>Staphylococcus aureus</italic></article-title><source>Infect Immun</source><year>2001</year><volume>69</volume><issue>4</issue><fpage>2448</fpage><lpage>55</lpage><pub-id pub-id-type="pmcid">PMC98178</pub-id><pub-id pub-id-type="pmid">11254606</pub-id><pub-id pub-id-type="doi">10.1128/IAI.69.4.2448-2455.2001</pub-id></element-citation></ref><ref id="R58"><label>58</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Krishna</surname><given-names>TC</given-names></name><name><surname>Najda</surname><given-names>A</given-names></name><name><surname>Bains</surname><given-names>A</given-names></name><name><surname>Tosif</surname><given-names>MM</given-names></name><name><surname>Papliński</surname><given-names>R</given-names></name><name><surname>Kapłan</surname><given-names>M</given-names></name><etal/></person-group><article-title>Influence of ultra-heat treatment on properties of milk proteins</article-title><source>Polymers (Basel)</source><year>2021</year><volume>13</volume><issue>18</issue><comment>Epub 20210918</comment><pub-id pub-id-type="pmcid">PMC8468757</pub-id><pub-id pub-id-type="pmid">34578063</pub-id><pub-id pub-id-type="doi">10.3390/polym13183164</pub-id></element-citation></ref><ref id="R59"><label>59</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhu</surname><given-names>M</given-names></name><name><surname>Qu</surname><given-names>J</given-names></name><name><surname>Deng</surname><given-names>Q</given-names></name></person-group><article-title>Identification of potential inhibitors against <italic>Staphylococcus aureus</italic> shikimate dehydrogenase through virtual screening and susceptibility test</article-title><source>J Enzyme Inhib Med Chem</source><year>2024</year><volume>39</volume><issue>1</issue><elocation-id>2301768</elocation-id><comment>Epub 20240117</comment><pub-id pub-id-type="pmcid">PMC10798293</pub-id><pub-id pub-id-type="pmid">38234148</pub-id><pub-id pub-id-type="doi">10.1080/14756366.2024.2301768</pub-id></element-citation></ref><ref id="R60"><label>60</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rios-Soto</surname><given-names>L</given-names></name><name><surname>Téllez-Valencia</surname><given-names>A</given-names></name><name><surname>Sierra-Campos</surname><given-names>E</given-names></name><name><surname>Valdez-Solana</surname><given-names>M</given-names></name><name><surname>Cisneros-Martínez</surname><given-names>J</given-names></name><name><surname>Gómez Palacio-Gastélum</surname><given-names>M</given-names></name><etal/></person-group><article-title>Finding the first potential inhibitors of shikimate kinase from methicillin resistant <italic>Staphylococcus aureus</italic> through computer-assisted drug design</article-title><source>Molecules</source><year>2021</year><volume>26</volume><issue>21</issue><elocation-id>6736</elocation-id><pub-id pub-id-type="pmcid">PMC8587801</pub-id><pub-id pub-id-type="pmid">34771148</pub-id><pub-id pub-id-type="doi">10.3390/molecules26216736</pub-id></element-citation></ref><ref id="R61"><label>61</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dengler</surname><given-names>V</given-names></name><name><surname>Meier</surname><given-names>PS</given-names></name><name><surname>Heusser</surname><given-names>R</given-names></name><name><surname>Berger-Bächi</surname><given-names>B</given-names></name><name><surname>McCallum</surname><given-names>N</given-names></name></person-group><article-title>Induction kinetics of the Staphylococcus aureus cell wall stress stimulon in response to different cell wall active antibiotics</article-title><source>BMC Microbiol</source><year>2011</year><volume>11</volume><fpage>16</fpage><comment>Epub 20110120</comment><pub-id pub-id-type="pmcid">PMC3032642</pub-id><pub-id pub-id-type="pmid">21251258</pub-id><pub-id pub-id-type="doi">10.1186/1471-2180-11-16</pub-id></element-citation></ref><ref id="R62"><label>62</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Löfblom</surname><given-names>J</given-names></name><name><surname>Kronqvist</surname><given-names>N</given-names></name><name><surname>Uhlén</surname><given-names>M</given-names></name><name><surname>Ståhl</surname><given-names>S</given-names></name><name><surname>Wernérus</surname><given-names>H</given-names></name></person-group><article-title>Optimization of electroporation-mediated transformation: <italic>Staphylococcus carnosus</italic> as model organism</article-title><source>J Appl Microbiol</source><year>2007</year><volume>102</volume><issue>3</issue><fpage>736</fpage><lpage>47</lpage><pub-id pub-id-type="pmid">17309623</pub-id></element-citation></ref><ref id="R63"><label>63</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Depardieu</surname><given-names>F</given-names></name><name><surname>Bikard</surname><given-names>D</given-names></name></person-group><article-title>Gene silencing with CRISPRi in bacteria and optimization of dCas9 expression levels</article-title><source>Methods</source><year>2020</year><volume>172</volume><fpage>61</fpage><lpage>75</lpage><comment>Epub 20190801</comment><pub-id pub-id-type="pmid">31377338</pub-id></element-citation></ref><ref id="R64"><label>64</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arnaud</surname><given-names>M</given-names></name><name><surname>Chastanet</surname><given-names>A</given-names></name><name><surname>Débarbouillé</surname><given-names>M</given-names></name></person-group><article-title>New vector for efficient allelic replacement in naturally nontransformable, low-GC-content, gram-positive bacteria</article-title><source>Appl Environ Microbiol</source><year>2004</year><volume>70</volume><issue>11</issue><fpage>6887</fpage><lpage>91</lpage><pub-id pub-id-type="pmcid">PMC525206</pub-id><pub-id pub-id-type="pmid">15528558</pub-id><pub-id pub-id-type="doi">10.1128/AEM.70.11.6887-6891.2004</pub-id></element-citation></ref><ref id="R65"><label>65</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Porcellato</surname><given-names>D</given-names></name><name><surname>Skeie</surname><given-names>SB</given-names></name></person-group><article-title>Bacterial dynamics and functional analysis of microbial metagenomes during ripening of Dutch-type cheese</article-title><source>Int Dairy J</source><year>2016</year><volume>61</volume><fpage>182</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1016/j.idairyj.2016.05.005</pub-id></element-citation></ref><ref id="R66"><label>66</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bravo</surname><given-names>AM</given-names></name><name><surname>Typas</surname><given-names>A</given-names></name><name><surname>Veening</surname><given-names>JW</given-names></name></person-group><article-title>2FAST2Q: a general-purpose sequence search and counting program for FASTQ files</article-title><source>PeerJ</source><year>2022</year><volume>10</volume><elocation-id>e14041</elocation-id><comment>Epub 20221025</comment><pub-id pub-id-type="pmcid">PMC9615965</pub-id><pub-id pub-id-type="pmid">36312750</pub-id><pub-id pub-id-type="doi">10.7717/peerj.14041</pub-id></element-citation></ref><ref id="R67"><label>67</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Love</surname><given-names>MI</given-names></name><name><surname>Huber</surname><given-names>W</given-names></name><name><surname>Anders</surname><given-names>S</given-names></name></person-group><article-title>Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2</article-title><source>Genome Biol</source><year>2014</year><volume>15</volume><issue>12</issue><fpage>550</fpage><pub-id pub-id-type="pmcid">PMC4302049</pub-id><pub-id pub-id-type="pmid">25516281</pub-id><pub-id pub-id-type="doi">10.1186/s13059-014-0550-8</pub-id></element-citation></ref><ref id="R68"><label>68</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhu</surname><given-names>A</given-names></name><name><surname>Ibrahim</surname><given-names>JG</given-names></name><name><surname>Love</surname><given-names>MI</given-names></name></person-group><article-title>Heavy-tailed prior distributions for sequence count data: removing the noise and preserving large differences</article-title><source>Bioinformatics</source><year>2018</year><volume>35</volume><issue>12</issue><fpage>2084</fpage><lpage>92</lpage><pub-id pub-id-type="pmcid">PMC6581436</pub-id><pub-id pub-id-type="pmid">30395178</pub-id><pub-id pub-id-type="doi">10.1093/bioinformatics/bty895</pub-id></element-citation></ref></ref-list></back><floats-group><fig id="F1" position="float"><label>Fig 1</label><caption><p><bold>(A)</bold> Schematic representation of P<sub>tet</sub>-<italic>dcas9</italic> on the <italic>S. aureus</italic> NCTC8325-4 chromosome, and the pVL2336-sgRNA(target) plasmid. <bold>(B)</bold> Verification of the tetracycline-inducible CRISPRi system in BHI. Growth curves of CRISPRi strains targeting <italic>pbp1</italic> (MM269) and a control strain harboring a non-targeting sgRNA (MM268) in BHI in the presence of varying concentrations of aTc, using a 4-fold dilution series from 7.5 ng/mL to 120 ng/mL. Optical density (OD<sub>600</sub>) was measured at 10-min intervals. Data represent the averages of three independent experiments, each consisting of three technical replicates. Error bars represent the standard error based on these three independent experiments. (<bold>C</bold>) Verification of the tetracycline-inducible CRISPRi system in UHT milk. CRISPRi strains targeting <italic>pbp1</italic> (MM269) and a control strain harboring a non-targeting sgRNA (MM268) were grown in UHT milk with or without induction with 30 ng/ml aTc for 24 hours, and CFU/ml was calculated at 0, 2, 4, 6 and 24 hours. The data represent the average of two independent experiments, with error bars indicating standard error.</p></caption><graphic xlink:href="EMS199801-f001"/></fig><fig id="F2" position="float"><label>Fig 2</label><caption><p><bold>(A)</bold> Schematic overview of the construction of a CRISPRi pooled library and the subsequent CRISPRi-seq screen. <bold>(B)</bold> Venn-diagram showing the comparison of essential genes in BHI versus UHT milk identified by CRISPRi-seq. The Venn diagram was created using eulerr.co <bold>(C)</bold> Fitness effects upon <italic>dcas9</italic> induction in BHI versus milk. Genes with significant differential fitness effects (|ΔL2FC| &gt; 1, P<sub>adj</sub> &lt; 0.05) are depicted in red, with larger points indicating more statistically significant effects. The top three genes with the largest differential L2FC in both directions are marked with labels. Vertical and horizontal dashed grey lines indicate the |L2FC| ≥ 1 threshold. Diagonal dashed grey lines represent the threshold where the difference in L2FC between BHI and UHT milk is greater than 1. Genes that fall far from these diagonal lines exhibit a larger differential fitness effect, highlighting conditionally essential genes. L2FC: log<sub>2</sub> fold change.</p></caption><graphic xlink:href="EMS199801-f002"/></fig><fig id="F3" position="float"><label>Fig 3</label><caption><p><bold>(A)</bold> Spotting assay of CRISPRi strains grown in UHT milk and BHI for ~ 20 generations in the presence of 30 ng/ml aTc. A 10-fold dilution series of each strain was prepared, and 5 μl of each dilution was spotted on BHI agar plates. The control strain harbors a non-targeting sgRNA. The assay was repeated twice with similar results. <bold>(B)</bold> CFU/ml of CRISPRi strains grown in BHI (red) and UHT milk (green) for ~ 20 generations in the presence of 30 ng/ml aTc. The relative fitness is presented as the percentage of CFU/ml of each strain relative to the control strain harboring a non-targeting sgRNA. Data represent the average and standard error based on three independent spotting assays. Statistical significance was determined using two-tailed t-tests comparing each strain against the control within each condition. Significance levels are indicated as follows: * <italic>p</italic> &lt; 0.05, ** <italic>p</italic> &lt; 0.01, *** <italic>p</italic> &lt; 0.001. <bold>(C).</bold> Overview of purine synthesis, folate synthesis, and the folate cycle in <italic>S. aureus</italic>. The figure depicts key metabolic pathways involved in the synthesis of purines and folate, and the interconnection of these pathways. Genes with differential log<sub>2</sub> fold change (L2FC) in milk compared to BHI from the CRISPRi-seq screen are indicated in blue (L2FC ≥ 1, <italic>p</italic> &lt; 0.05) or red (L2FC ≤ -1, <italic>p</italic> &lt; 0.05). The purine biosynthetic pathway (highlighted in pink) details sequential conversion of phosphoribosyl pyrophosphate (PRPP) to inosine monophosphate (IMP) and subsequent generation of adenosine triphosphate (ATP) and guanosine triphosphate (GTP). GTP is connected to <italic>de novo</italic> folate biosynthesis, where it serves as a substrate in the production of 7,8-dihydroneopterin triphosphate (DHN-3P), an early precursor in the folate pathway. In the <italic>de novo</italic> folate biosynthesis pathway (highlighted in yellow), para-aminobenzoic acid (PABA) is synthesized through the Shikimate and Chorismate pathways and combines with 6-hydroxymethyldihydropterin pyrophosphate (HMDHP-2P) to generate dihydropteroate (DHP), which is converted to dihydrofolate (DHF). DHF is further processed within the folate cycle (highlighted in green), where it is reduced to tetrahydrofolate (THF), which then participates in the one-carbon pool essential for the biosynthesis of nucleotides, amino acids, and other key metabolites. The figure also highlights the inhibition points of trimethoprim (TMP) and sulfamethoxazole (SMX), which targets dihydrofolate reductase (DfrA) and dihydropteroate synthase (FolP), respectively. Abbreviations: PRPP: phosphoribosyl pyrophosphate; PRA: 5-phosphoribosylamine; GAR: 5’- phosphoribosylglycinamide; FGAR: 5’-phosphoribosyl-N-formylglycinamide; FGAM: 2-(formamido)-N1-(5’-phosphoribosyl)acetamidine; AIR: aminoimidazole ribotide; CAIR: 1-(5’-phosphoribosyl)-5-amino-4-imidazolecarboxylate; SAICAR: 1-(5’-phosphoribosyl)-5-amino-4-(N-succinocarboxamide)-imidazole; AICAR: 1-(5’-phosphoribosyl)-5-amino-4-imidazolecarboxamide; FAICAR: 1-(5’-phosphoribosyl)-5-formamido-4-imidazolecarboxamide; IMP: inosine monophosphate; AMP: adenosine monophosphate; ADP: adenosine diphosphate; dADP: deoxyadenosine diphosphate; ATP: adenosine triphosphate; XMP: xanthosine monophosphate; GMP: guanosine monophosphate; GDP: guanosine diphosphate; dGDP: deoxyguanosine diphosphate; GTP: guanosine triphosphate; DHN-3P: 7,8-dihydroneopterin triphosphate; DHN: 7,8-dihydroneopterin; HMDHP: 6-hydroxymethyl-7,8-dihydropterin; HMDHP-2P: 6-hydroxymethyldihydropterin pyrophosphate; DHP: dihydropteroate; DHF: dihydrofolate; THF: tetrahydrofolate; MTHF: 5,10-methylene tetrahydrofolate; dUMP: deoxyuridine monophosphate; dTMP: deoxythymidine monophosphate; TMP: trimethoprim; SMX: sulfamethoxazole; PABA: para-aminobenzoic acid.</p></caption><graphic xlink:href="EMS199801-f003"/></fig><fig id="F4" position="float"><label>Fig 4</label><caption><p><bold>(A)</bold> Increased sensitivity of <italic>S. aureus</italic> to trimethoprim-sulfamethoxazole (TMP-SMX) in milk compared to brain heart infusion (BHI) medium. Cultures of <italic>S. aureus</italic> NCTC8325-4 were diluted 1/1000 in BHI and milk containing a 2-fold dilution of TMP-SMX starting from 0.8 μg/ml TMP and 4.0 μg/ml SMX and subsequently incubated at 37°C for 6 hours. CFU/ml was calculated from 5 μl aliquots spotted on BHI agar plates for each condition. Data represent the mean of two independent experiments, with error bars indicating standard errors. <bold>(B)</bold> Fitness effects upon <italic>dcas9</italic> induction in milk with TMP-SMX versus without TMP-SMX. Genes with significant differential fitness effects (|L2FC| ≥ 1, <italic>P<sub>adj</sub></italic> &lt; 0.05) are depicted in red, with larger points indicating more statistically significant effects. Conditionally essential genes selected for follow-up experiments are marked with labels. Vertical and horizontal dashed grey lines indicate the |L2FC| ≥ 1 threshold. Diagonal dashed grey lines represent the threshold where the absolute difference in L2FC between +/- TMP-SMX is greater than 1. Genes that fall far from these diagonal lines exhibit a larger differential fitness effect, highlighting conditionally essential genes. L2FC: log<sub>2</sub> fold change. <bold>(C)</bold> Spotting assay of CRISPRi strains grown in UHT milk (top) or BHI (bottom) for ~ 20 generations in the presence of 0.1 μg/ml TMP and 0.5 μg/ml SMX. 30 ng/ml aTc was added for induction of dCas9 expression. A 10-fold dilution series of each strain was prepared, and 5 μl of each dilution was spotted on BHI agar plates. The control strain harbors a non-targeting sgRNA. <bold>(D)</bold> Relative fitness of CRISPRi strains grown in UHT milk (green) and BHI (red). Relative fitness is presented as the percentage of CFU/ml of each strain relative to the control strain harboring a non-targeting sgRNA. Data represent the average and standard deviation based on three independent experiments. Statistical significance was determined using two-tailed t-tests comparing each strain against the control within the same condition. Significance levels are indicated as follows: * <italic>p</italic> &lt; 0.05, ** <italic>p</italic> &lt; 0.01, *** <italic>p</italic> &lt; 0.001. (<bold>E</bold>) Schematic illustration of the folate pathway, illustrating the role of NupC in the process. See also legend to <xref ref-type="fig" rid="F3">Fig 3</xref> for abbreviations.</p></caption><graphic xlink:href="EMS199801-f004"/></fig><fig id="F5" position="float"><label>Fig 5</label><caption><p><bold>(A)</bold> Spotting assay of CRISPRi strains grown in UHT milk (top) and BHI (bottom) for ~20 generations in the presence of 30 ng/ml aTc. A 10-fold dilution series of each strain was prepared, and 5 μl of each dilution was spotted on BHI agar plates. The control strain harbors a non-targeting sgRNA. <bold>(B)</bold> Relative fitness of CRISPRi strains grown in BHI (red) and UHT milk (green) for ~ 20 generations in the presence of 30 ng/ml aTc. CFU/ml was calculated based on two independent spotting assays, and the relative fitness is presented as the percentage of CFU/ml of each strain relative to the control strain harboring a non-targeting sgRNA. Data represent the average and standard errors based on three independent experiments. Statistical significance was determined using two-tailed t-tests comparing each strain against the control within each condition. Significance levels are indicated as follows: * <italic>p</italic> &lt; 0.05, ** <italic>p</italic> &lt; 0.01, *** <italic>p</italic> &lt; 0.001.</p></caption><graphic xlink:href="EMS199801-f005"/></fig><fig id="F6" position="float"><label>Fig 6</label><caption><p>Survival of <italic>S. aureus</italic> in response to tunicamycin (A) and targocil (B) treatment in BHI and milk. Overnight cultures of <italic>S. aureus</italic> were diluted 1:1000 in BHI and milk, exposed to tunicamycin or targocil in a 2-fold dilution series, starting at 16 μg/ml and 4 μg/ml, respectively. Cultures were incubated at 37 °C for 6 hours before 10-fold dilutions were spotted onto BHI agar. <italic>S. aureus</italic> survival was calculated as the percentage of CFU/ml relative to untreated cultures. Data represent the average and standard errors based on two independent experiments.</p></caption><graphic xlink:href="EMS199801-f006"/></fig><table-wrap id="T1" position="float" orientation="portrait"><label>Table 1</label><caption><title>List of genes more important for fitness in milk as determined by CRISPRi-seq.</title></caption><table frame="hsides" rules="rows"><thead><tr><th align="center" valign="middle">Locus tag targeted (SAOUHSC)</th><th align="center" valign="middle">Target gene(s)<sup><xref ref-type="table-fn" rid="TFN1">a</xref></sup></th><th align="center" valign="middle">Function/pathway<sup><xref ref-type="table-fn" rid="TFN2">b</xref></sup></th><th align="center" valign="middle">Interaction L2FC<sup><xref ref-type="table-fn" rid="TFN3">c</xref></sup></th><th align="center" valign="middle">Interaction P<sub>adj</sub><sup><xref ref-type="table-fn" rid="TFN3">c</xref></sup></th></tr></thead><tbody><tr><td align="center" valign="middle">_02126</td><td align="center" valign="middle"><italic>purB</italic></td><td align="center" valign="middle">Purine/AMP biosynthesis</td><td align="center" valign="middle">-10.5</td><td align="center" valign="middle">1.3E-12</td></tr><tr><td align="center" valign="middle">_02430</td><td align="center" valign="middle"><italic>htsABC</italic></td><td align="center" valign="middle">Iron uptake (siderophore system)</td><td align="center" valign="middle">-7.5</td><td align="center" valign="middle">5.6E-21</td></tr><tr><td align="center" valign="middle">_00652</td><td align="center" valign="middle"><italic>fhuCBG</italic></td><td align="center" valign="middle">Iron uptake (siderophore system)</td><td align="center" valign="middle">-7.2</td><td align="center" valign="middle">3.4E-15</td></tr><tr><td align="center" valign="middle">_02139</td><td align="center" valign="middle"><italic>pncA-ppaC</italic></td><td align="center" valign="middle">Putative nicotinamidase - pyrophosphatase</td><td align="center" valign="middle">-7.1</td><td align="center" valign="middle">4.9E-18</td></tr><tr><td align="center" valign="middle">_01216</td><td align="center" valign="middle"><italic>sucCD</italic></td><td align="center" valign="middle">Succinyl-CoA synthetase, TCA cycle</td><td align="center" valign="middle">-6.4</td><td align="center" valign="middle">8.3E-19</td></tr><tr><td align="center" valign="middle">_01435</td><td align="center" valign="middle"><italic>thyA</italic></td><td align="center" valign="middle">Thymidylate synthase, dTMP synthesis</td><td align="center" valign="middle">-5.7</td><td align="center" valign="middle">5.0E-03</td></tr><tr><td align="center" valign="middle">_02158</td><td align="center" valign="middle"><italic>aspB</italic></td><td align="center" valign="middle">Aspartate transaminase</td><td align="center" valign="middle">-5.1</td><td align="center" valign="middle">6.4E-26</td></tr><tr><td align="center" valign="middle">_00019</td><td align="center" valign="middle"><italic>purA</italic></td><td align="center" valign="middle">Purine biosynthesis</td><td align="center" valign="middle">-4.8</td><td align="center" valign="middle">5.4E-19</td></tr><tr><td align="center" valign="middle">_01008</td><td align="center" valign="middle"><italic>purEKCSQ-LFMNHD</italic></td><td align="center" valign="middle">Purine biosynthesis</td><td align="center" valign="middle">-4.6</td><td align="center" valign="middle">9.7E-51</td></tr><tr><td align="center" valign="middle">_00637</td><td align="center" valign="middle"><italic>mntABC</italic></td><td align="center" valign="middle">Manganese ABC-transporter</td><td align="center" valign="middle">-4.3</td><td align="center" valign="middle">6.7E-14</td></tr><tr><td align="center" valign="middle">_00790</td><td align="center" valign="middle"><italic>clpP</italic></td><td align="center" valign="middle">Clp protease</td><td align="center" valign="middle">-4.0</td><td align="center" valign="middle">6.6E-11</td></tr><tr><td align="center" valign="middle">_00743</td><td align="center" valign="middle"><italic>nrdF</italic></td><td align="center" valign="middle">Ribonucleotide-diphosphate reductase</td><td align="center" valign="middle">-4.0</td><td align="center" valign="middle">3.6E-02</td></tr><tr><td align="center" valign="middle">_00274</td><td align="center" valign="middle">00274</td><td align="center" valign="middle">Type VII secretion system, DUF600</td><td align="center" valign="middle">-3.9</td><td align="center" valign="middle">3.6E-12</td></tr><tr><td align="center" valign="middle">_00269</td><td align="center" valign="middle"><italic>esaG</italic></td><td align="center" valign="middle">Type VII secretion system immunity</td><td align="center" valign="middle">-3.3</td><td align="center" valign="middle">5.7E-05</td></tr><tr><td align="center" valign="middle">_01007</td><td align="center" valign="middle"><italic>folD</italic></td><td align="center" valign="middle">5,10-methylene-tetrahydrofolate dehydrogenase</td><td align="center" valign="middle">-3.1</td><td align="center" valign="middle">1.2E-25</td></tr><tr><td align="center" valign="middle">_00573</td><td align="center" valign="middle"><italic>hemQ</italic></td><td align="center" valign="middle">Heme peroxidase</td><td align="center" valign="middle">-3.1</td><td align="center" valign="middle">2.8E-02</td></tr><tr><td align="center" valign="middle">_00551</td><td align="center" valign="middle">00551<italic>-bshB2- folE2</italic></td><td align="center" valign="middle"/><td align="center" valign="middle">-3.0</td><td align="center" valign="middle">2.3E-04</td></tr><tr><td align="center" valign="middle">_01326</td><td align="center" valign="middle">01326</td><td align="center" valign="middle">Amino acid permease</td><td align="center" valign="middle">-2.9</td><td align="center" valign="middle">9.9E-10</td></tr><tr><td align="center" valign="middle">_01064</td><td align="center" valign="middle"><italic>pycA</italic></td><td align="center" valign="middle">Pyruvate carboxylase</td><td align="center" valign="middle">-2.4</td><td align="center" valign="middle">1.3E-12</td></tr><tr><td align="center" valign="middle">_00957</td><td align="center" valign="middle">00957</td><td align="center" valign="middle">TerC family integral membrane protein</td><td align="center" valign="middle">-2.1</td><td align="center" valign="middle">1.2E-03</td></tr><tr><td align="center" valign="middle">_00341</td><td align="center" valign="middle"><italic>metICFE</italic></td><td align="center" valign="middle">Methionine biosynthesis</td><td align="center" valign="middle">-2.1</td><td align="center" valign="middle">1.9E-04</td></tr><tr><td align="center" valign="middle">_00358</td><td align="center" valign="middle">00358</td><td align="center" valign="middle">Integral membrane protein</td><td align="center" valign="middle">-2.0</td><td align="center" valign="middle">1.2E-04</td></tr><tr><td align="center" valign="middle">_00620</td><td align="center" valign="middle"><italic>sarA</italic></td><td align="center" valign="middle">Staphylococcal accessory regulator A</td><td align="center" valign="middle">-1.9</td><td align="center" valign="middle">7.1E-04</td></tr><tr><td align="center" valign="middle">_01908</td><td align="center" valign="middle"><italic>smdA</italic></td><td align="center" valign="middle">Cell morphology determinant</td><td align="center" valign="middle">-1.9</td><td align="center" valign="middle">1.3E-03</td></tr><tr><td align="center" valign="middle">_00542</td><td align="center" valign="middle">00542<italic>-azo1</italic></td><td align="center" valign="middle">HAD superfamily hydrolase - FMN reductase</td><td align="center" valign="middle">-1.5</td><td align="center" valign="middle">3.7E-02</td></tr></tbody></table><table-wrap-foot><fn id="TFN1"><label>a</label><p id="P42">Genes in the same operon as the target gene is also indicated.</p></fn><fn id="TFN2"><label>b</label><p id="P43">Functional characterization from AureoWiki [<xref ref-type="bibr" rid="R24">24</xref>].</p></fn><fn id="TFN3"><label>c</label><p id="P44">L2FC (log<sub>2</sub> fold change) in fitness upon CRISPRi depletion and adjusted <italic>p</italic>-values (P<sub>adj</sub>) from DESeq2 analysis</p></fn></table-wrap-foot></table-wrap><table-wrap id="T2" position="float" orientation="portrait"><label>Table 2</label><caption><title>Selected genes resulting in increased sensitivity to TMP-SMX upon depletion</title></caption><table frame="hsides" rules="rows"><thead><tr><th align="center" valign="middle">Locus tag targeted (SAOUHSC)</th><th align="center" valign="middle">Target gene(s)<sup><xref ref-type="table-fn" rid="TFN4">a</xref></sup></th><th align="center" valign="middle">Function<sup><xref ref-type="table-fn" rid="TFN5">b</xref></sup></th><th align="center" valign="middle">Interaction L2FC<sup><xref ref-type="table-fn" rid="TFN6">c</xref></sup></th><th align="center" valign="middle">Interaction P<sub>adj</sub><sup><xref ref-type="table-fn" rid="TFN6">c</xref></sup></th></tr></thead><tbody><tr><td align="center" valign="middle">03049</td><td align="center" valign="middle">noc</td><td align="center" valign="middle">nucleoid occlusion protein</td><td align="center" valign="middle">-2,8</td><td align="center" valign="middle">4,66E-57</td></tr><tr><td align="center" valign="middle">_1782</td><td align="center" valign="middle"><italic>01782-01781</italic></td><td align="center" valign="middle">unknown</td><td align="center" valign="middle">-3,4</td><td align="center" valign="middle">3,71E-29</td></tr><tr><td align="center" valign="middle">_02121</td><td align="center" valign="middle"><italic>02121</italic></td><td align="center" valign="middle">unknown</td><td align="center" valign="middle">-2,1</td><td align="center" valign="middle">3,89E-25</td></tr><tr><td align="center" valign="middle">_00564</td><td align="center" valign="middle"><italic>ung</italic></td><td align="center" valign="middle">uracil-DNA glycosylase</td><td align="center" valign="middle">-1,9</td><td align="center" valign="middle">2,44E-13</td></tr><tr><td align="center" valign="middle">_00501</td><td align="center" valign="middle"><italic>nupC</italic></td><td align="center" valign="middle">nucleoside permease</td><td align="center" valign="middle">-5,9</td><td align="center" valign="middle">1,85E-08</td></tr><tr><td align="center" valign="middle">_00752</td><td align="center" valign="middle"><italic>murB-00751</italic></td><td align="center" valign="middle">UDP-N-acetylenolpyruvoyl-glucosamine reductase</td><td align="center" valign="middle">-3,3</td><td align="center" valign="middle">1,66E-07</td></tr><tr><td align="center" valign="middle">_01797</td><td align="center" valign="middle"><italic>polA</italic></td><td align="center" valign="middle">DNA polymerase I</td><td align="center" valign="middle">-1,5</td><td align="center" valign="middle">4,43E-05</td></tr><tr><td align="center" valign="middle">_00648</td><td align="center" valign="middle"><italic>nupG</italic></td><td align="center" valign="middle">nucleoside transport protein</td><td align="center" valign="middle">-1,9</td><td align="center" valign="middle">0,003</td></tr></tbody></table><table-wrap-foot><fn id="TFN4"><label>a</label><p id="P45">Genes in the same operon as the target gene is also indicated.</p></fn><fn id="TFN5"><label>b</label><p id="P46">Functional characterization from <italic>Aureo</italic> Wiki [<xref ref-type="bibr" rid="R24">24</xref>].</p></fn><fn id="TFN6"><label>c</label><p id="P47">L2FC (log<sub>2</sub> fold change) in fitness upon CRISPRi depletion and adjusted <italic>p</italic>-values (P<sub>adj</sub>) from DESeq2 analysis</p></fn></table-wrap-foot></table-wrap></floats-group></article>